Patent Grant
11672658
Some embodiments of the present invention relate in general to valve replacement. More specifically, some embodiments of the present invention relate to prosthetic valves for replacement of a cardiac valve.
Ischemic heart disease causes regurgitation of a heart valve by the combination of ischemic dysfunction of the papillary muscles, and the dilatation of the ventricle that is present in ischemic heart disease, with the subsequent displacement of the papillary muscles and the dilatation of the valve annulus.
Dilatation of the annulus of the valve prevents the valve leaflets from fully coapting when the valve is closed. Regurgitation of blood from the ventricle into the atrium results in increased total stroke volume and decreased cardiac output, and ultimate weakening of the ventricle secondary to a volume overload and a pressure overload of the atrium.
For some embodiments of the present invention, an implant is provided having a tubular portion, an upstream support portion and one or more flanges. The implant is percutaneously deliverable to a native heart valve in a compressed state, and is expandable at the native valve. The implant and its delivery system facilitate causing the upstream support portion and the flanges to protrude radially outward from the tubular portion without expanding the tubular portion. Expansion of the tubular portion brings the upstream support portion and the flanges closer together, for securing the implant at the native valve by sandwiching tissue of the native valve between the upstream support portion and the flanges.
In accordance with an embodiment of the present invention, an apparatus is provided for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject, the apparatus including: a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis; a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen; an outer frame: including a ring defined by a pattern of alternating peaks and troughs, the peaks being longitudinally closer to the upstream end than to the downstream end, and the troughs being longitudinally closer to the downstream end than to the upstream end, and the pattern of the ring having an amplitude longitudinally between the peaks and the troughs, including a plurality of legs, each of the legs coupled to the ring at a respective trough, and shaped to define a plurality of outer-frame coupling elements, each of the outer-frame coupling elements (i) coupled to the ring at a respective peak, and (ii) fixed with respect to a respective valve-frame coupling element, and: the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and the fixation of the outer-frame coupling elements to the valve-frame coupling elements is such that compression of the tubular portion from the expanded state toward the compressed state such that the valve-frame coupling elements pull the outer-frame coupling elements radially inward: (i) reduces a circumferential distance between each of the outer-frame coupling elements and its adjacent outer-frame coupling elements, and (ii) increases the amplitude of the pattern of the ring.
In an embodiment, the ring circumscribes the tubular portion.
In an embodiment, the valve-frame coupling elements are disposed circumferentially around the longitudinal axis between the upstream end and the downstream end but not at the upstream end nor at the downstream end.
In an embodiment, the upstream support portion includes one or more fabric pockets disposed circumferentially, each pocket of the one or more pockets having an opening that faces a downstream direction.
In an embodiment, the outer frame is coupled to the valve frame only via the fixation of the outer-frame coupling elements to the respective valve-frame coupling elements.
In an embodiment, the apparatus further includes an upstream support portion that includes a plurality of arms that extend radially from the tubular portion, and the upstream support portion has (i) a constrained-arm state, and (ii) a released-arm state in which the arms extend radially outward from the tubular portion, each leg has a tissue-engaging flange that has (i) a constrained-flange state, and (ii) a released-flange state in which the flange extends radially outward from the tubular portion, and the apparatus has an intermediate state in which (i) the tubular portion is in its compressed state, (ii) the upstream support portion is in its released-arm state, and (iii) the legs are in their released-flange state.
In an embodiment, the apparatus includes an implant that includes the valve frame, the leaflets, and the outer frame, and the apparatus further includes a tool: including a delivery capsule dimensioned (i) to house and retain the implant in a compressed state of the implant in which (a) the tubular portion is in its compressed state, (b) the upstream support portion is in its constrained-arm state, and (c) the legs are in their constrained-flange state, and (ii) to be advanced percutaneously to the heart of the subject while the implant is housed and in its compressed state, and operable from outside the subject to: transition the implant from its compressed state into the intermediate state while retaining the tubular portion in its compressed state, and subsequently, expand the tubular portion toward its expanded state.
In an embodiment, the tool is operable from outside the subject to transition the implant from its compressed state into the intermediate state by (i) releasing the legs into their released-flange state, while retaining the tubular portion in its compressed state, and (ii) subsequently, releasing the upstream support portion into its released-arm state, while retaining the tubular portion in its compressed state.
In an embodiment, the tool is operable from outside the subject to transition the implant from its compressed state into the intermediate state by (i) releasing the upstream support portion into its released-arm state, while retaining the tubular portion in its compressed state, and (ii) subsequently, releasing the legs into their released-flange state, while retaining the tubular portion in its compressed state.
In an embodiment, the fixation of the outer-frame coupling elements to the valve-frame coupling elements is such that, when the apparatus is in its intermediate state, expansion of the tubular portion from its compressed state toward its expanded state moves the flanges longitudinally away from the valve-frame coupling elements.
In an embodiment, the fixation of the outer-frame coupling elements to the valve-frame coupling elements is such that, when the apparatus is in its intermediate state, expansion of the tubular portion from a compressed state toward an expanded state reduces the amplitude of the pattern of the ring and passes the flanges between the arms.
In an embodiment, the upstream support portion further includes a covering that covers the arms to form an annular shape in the released-arm state, and, when the apparatus is in its intermediate state, expansion of the tubular portion from its compressed state toward its expanded state presses the flanges onto the covering.
In an embodiment, in the compressed state of the tubular portion, a downstream end of each leg of the tubular portion is longitudinally closer than the valve-frame coupling elements to the downstream end, and the flange of each leg is disposed longitudinally closer than the valve-frame coupling elements to the upstream end.
In an embodiment, in the expanded state of the tubular portion, the downstream end of each leg is longitudinally closer than the valve-frame coupling elements to the downstream end, and the flange of each leg is disposed longitudinally closer than the valve-frame coupling elements to the upstream end.
In accordance with an embodiment of the present invention, an apparatus for use with a native valve of a heart of a subject is provided, the apparatus having an implant that includes: a valve frame that includes a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion having an upstream end, a downstream end, a longitudinal length therebetween, and a diameter transverse to the longitudinal axis; a valve member, coupled to the tubular portion, disposed within the lumen, and arranged to provide unidirectional upstream-to-downstream flow of blood through the lumen; an upstream support portion, coupled to the tubular portion; and an outer frame, coupled to the tubular portion, and including a tissue-engaging flange, and: the implant has a first state and a second state, in both the first state and the second state, (i) the upstream support portion extends radially outward from the tubular portion, and (ii) the tissue-engaging flange extends radially outward from the tubular portion, and the tubular portion, the upstream support portion, and the outer frame are arranged such that transitioning of the implant from the first state toward the second state: increases the diameter of the tubular portion by a diameter-increase amount, decreases the length of the tubular portion by a length-decrease amount, and moves the flange a longitudinal distance toward or toward-and-beyond the upstream support portion, the distance being greater than the length-decrease amount.
In an embodiment of the present invention, the tubular portion, the upstream support portion, and the outer frame may be arranged such that the longitudinal distance is more than 20 percent greater than the length-decrease amount.
In an embodiment, the tubular portion, the upstream support portion, and the outer frame may be arranged such that the longitudinal distance is more than 30 percent greater than the length-decrease amount.
In an embodiment, the tubular portion, the upstream support portion, and the outer frame may be arranged such that the longitudinal distance is more than 40 percent greater than the length-decrease amount.
In accordance with an embodiment of the present invention, an apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject is provided, the apparatus including: a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis; a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen; an outer frame, including: a ring defined by a pattern of alternating peaks and troughs: the peaks being longitudinally closer than the troughs to the upstream end, the peaks being fixed to respective sites of the tubular portion at respective coupling points disposed circumferentially around the longitudinal axis, and the pattern of the ring having an amplitude longitudinally between the peaks and the troughs; and a plurality of legs, each of the legs coupled to the ring at a respective trough, and: the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and the fixation of the peaks to the respective sites of the tubular portion is such that compression of the tubular portion from the expanded state toward the compressed state such that the respective sites of the tubular portion pull the peaks radially inward via radially-inward tension on the coupling points: (i) reduces a circumferential distance between each of the coupling points and its adjacent coupling points, and (ii) increases the amplitude of the pattern of the ring.
In an embodiment, the outer frame may be coupled to the valve frame only via the fixation of the peaks to the respective sites of the tubular portion at the respective coupling points.
In accordance with an embodiment of the present invention, an apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject is provided, the apparatus including: a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the valve frame defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis; a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen; an outer frame: including a ring defined by a pattern of alternating peaks and troughs, the peaks being longitudinally closer to the upstream end than to the downstream end, and the troughs being longitudinally closer to the downstream end than to the upstream end, and the pattern of the ring having an amplitude longitudinally between the peaks and the troughs, including a plurality of legs, each of the legs coupled to the ring at a respective trough, and shaped to define a plurality of outer-frame coupling elements, each of the outer-frame coupling elements (i) coupled to the ring at a respective peak, and (ii) fixed with respect to a respective valve-frame coupling element, and: the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and the fixation of the outer-frame coupling elements with respect to the valve-frame coupling elements is such that compression of the tubular portion from the expanded state toward the compressed state (i) pulls the outer-frame coupling elements radially inward via radially-inward pulling of the valve-frame coupling elements on the outer-frame coupling elements, (ii) reduces a circumferential distance between each of the outer-frame coupling elements and its adjacent outer-frame coupling elements, and (iii) increases the amplitude of the pattern of the ring, without increasing a radial gap between the valve frame and the ring by more than 1.5 mm.
In an embodiment, the outer frame may be coupled to the valve frame only via the fixation of the outer-frame coupling elements to the respective valve-frame coupling elements.
There is further provided, in accordance with an embodiment of the present invention, an apparatus for use with a native valve that is disposed between an atrium and a ventricle of a heart of a subject is provided, the apparatus including: a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis; a plurality of prosthetic leaflets, coupled to the frame, disposed within the lumen, and arranged to provide unidirectional flow of blood from an upstream end of the lumen to a downstream end of the lumen; an outer frame, including: a ring defined by a pattern of alternating peaks and troughs: the peaks being longitudinally closer than the troughs to the upstream end, the peaks being fixed to respective sites of the tubular portion at respective coupling points disposed circumferentially around the longitudinal axis, and the pattern of the ring having an amplitude longitudinally between the peaks and the troughs; and a plurality of legs, each of the legs coupled to the ring at a respective trough, and: the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and the fixation of the peaks to the respective sites of the tubular portion is such that compression of the tubular portion from the expanded state toward the compressed state (i) pulls the peaks radially inward via radially-inward pulling of the respective sites of the tubular portion on the peaks, (ii) reduces a circumferential distance between each of the coupling points and its adjacent coupling points, and (iii) increases the amplitude of the pattern of the ring, without increasing a radial gap between the valve frame and the ring by more than 1.5 mm.
In an embodiment, the outer frame may be coupled to the valve frame only via the fixation of the peaks to the respective sites of the tubular portion at the respective coupling points.
In accordance with an embodiment of the present invention, an apparatus for use with a native valve disposed between an atrium and a ventricle of a heart of a subject is provided, the apparatus including: a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion having an upstream end, a downstream end, and defining a plurality of valve-frame coupling elements disposed circumferentially around the longitudinal axis between the upstream end and the downstream end but not at the upstream end nor at the downstream end; a plurality of prosthetic leaflets, disposed within the lumen, and arranged to provide unidirectional flow of blood through the lumen; an outer frame: including a ring defined by a pattern of alternating peaks and troughs, the peaks being longitudinally closer to the upstream end than to the downstream end, and the troughs being longitudinally closer to the downstream end than to the upstream end, including a plurality of legs, each of the legs coupled to the ring at a respective trough, and shaped to define a plurality of outer-frame coupling elements, each of the outer-frame coupling elements (i) coupled to the ring at a respective peak, and (ii) fixed with respect to a respective valve-frame coupling element at a respective coupling point, and: the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and expansion of the tubular portion from the compressed state toward the expanded state (i) increases a circumferential distance between each of the outer-frame coupling elements and its adjacent outer-frame coupling elements, and (ii) moves the plurality of legs in a longitudinally upstream direction with respect to the tubular portion.
In an embodiment, the outer frame may be coupled to the valve frame only via the fixation of the outer-frame coupling elements to the respective valve-frame coupling elements.
In accordance with an embodiment of the present invention, an apparatus for use with a native valve disposed between an atrium and a ventricle of a heart of a subject is provided, the apparatus including: a valve frame, including a tubular portion that circumscribes a longitudinal axis of the valve frame so as to define a lumen along the axis, the tubular portion having an upstream end and a downstream end; a plurality of prosthetic leaflets, disposed within the lumen, and arranged to provide unidirectional flow of blood through the lumen; an outer frame, including: a ring defined by a pattern of alternating peaks and troughs: the peaks being longitudinally closer than the troughs to the upstream end, the peaks being fixed to respective sites of the tubular portion at respective coupling points disposed circumferentially around the longitudinal axis between the upstream end and the downstream end but not at the upstream end nor the downstream end; and a plurality of legs, each of the legs coupled to the ring at a respective trough, and: the tubular portion has (i) a compressed state in which the tubular portion has a compressed diameter, and (ii) an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and expansion of the tubular portion from the compressed state toward the expanded state (i) increases a circumferential distance between each of the coupling points and its adjacent coupling points, and (ii) moves the plurality of legs in a longitudinally upstream direction with respect to the tubular portion.
In an embodiment, the outer frame may be coupled to the valve frame only via the fixation of the peaks to the respective sites of the tubular portion at the respective coupling points.
In accordance with an embodiment of the present invention, an apparatus for use with a native valve of a heart of a subject is provided, the apparatus including: a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, and including: a valve frame, including: a tubular portion having an upstream end and a downstream end, and shaped to define a lumen therebetween, and an upstream support portion, extending from the upstream end of the tubular portion; and at least one leg, coupled to the valve frame at a coupling point, and having a tissue-engaging flange; and a valve member disposed within the lumen, and configured to facilitate one-way liquid flow through the lumen from the upstream end of the tubular portion to the downstream end of the tubular portion, and the frame assembly: has a compressed state, for percutaneous delivery to the heart, in which the tubular portion has a compressed diameter, is biased to assume an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and is configured such that increasing the diameter of the tubular portion toward the expanded diameter causes longitudinal movement: of the upstream support portion toward the coupling point, and of the tissue-engaging flange away from the coupling point.
In an embodiment: the apparatus includes an implant that includes the frame assembly and the valve member, and the apparatus further includes a tool: including a delivery capsule dimensioned (i) to house and retain the implant in the compressed state, and (ii) to be advanced percutaneously to the heart of the subject while the implant is housed and in the compressed state, and operable from outside the subject to facilitate an increase of the diameter of the tubular portion from the compressed diameter toward the expanded diameter such that the increase of the diameter actuates longitudinal movement: of the upstream support portion toward the coupling point, and of the tissue-engaging flange away from the coupling point.
In an embodiment, the frame assembly may be configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes longitudinal movement of the upstream end of the tubular portion toward the coupling point.
In an embodiment, the coupling point is disposed closer to the downstream end of the frame assembly than are either the tissue-engaging flange or the upstream support portion.
In an embodiment, in the expanded state of the frame assembly, the leg extends away from the central longitudinal axis.
In an embodiment, the expanded state of the frame assembly may be a fully-expanded state of the frame assembly, the leg is expandable into an expanded state of the leg, independently of increasing the diameter of the tubular portion, and in the expanded state of the leg, the leg extends away from the central longitudinal axis.
In an embodiment, in the expanded state of the frame assembly, the leg extends away from the central longitudinal axis, and in the compressed state of the frame assembly, the leg is generally parallel with the central longitudinal axis.
In an embodiment, the frame assembly may be configured such that the longitudinal movement of the tissue-engaging flange away from the coupling point is a translational movement of the tissue-engaging flange that does not include rotation of the tissue-engaging flange.
In an embodiment, the frame assembly may be configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes 1-20 mm of longitudinal movement of the tissue-engaging flange away from the coupling point.
In an embodiment, the frame assembly may be configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes 1-20 mm of longitudinal movement of the upstream support portion toward the coupling point.
In an embodiment, the frame assembly may be configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state reduces a distance between the upstream support portion and the tissue-engaging flange by 5-30 mm.
In an embodiment, the frame assembly may be configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state moves the tissue-engaging flange longitudinally past the upstream support portion.
In an embodiment, the tubular portion may be defined by a plurality of cells of the valve frame, and increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state: includes (i) increasing a width, orthogonal to the longitudinal axis of the frame assembly, of each cell, and (ii) reducing a height, parallel with the longitudinal axis of the frame assembly, of each cell, and causes longitudinal movement of the upstream support portion toward the coupling point by reducing a height, parallel with the longitudinal axis of the frame assembly, of the tubular portion, by reducing the height of each cell.
In an embodiment, the leg is disposed on an outside of the tubular portion.
In an embodiment, the at least one leg includes a plurality of legs, the coupling point includes a plurality of coupling points, and the frame assembly includes a leg frame that circumscribes the tubular portion, includes the plurality of legs, and is coupled to the valve frame at the plurality of coupling points, such that the plurality of legs is distributed circumferentially around the tubular portion.
In an embodiment, the plurality of coupling points is disposed circumferentially around the frame assembly on a transverse plane that is orthogonal to the longitudinal axis of the frame assembly.
In an embodiment, the plurality of legs may be coupled to the valve frame via a plurality of struts, each strut having a first end that is coupled to a leg of the plurality of legs, and a second end that is coupled to a coupling point of the plurality of coupling points, in the compressed state of the frame assembly, being disposed at a first angle in which the first end is disposed closer to the downstream end of the frame assembly than is the second end, and being deflectable with respect to the coupling point of the plurality of coupling points, such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes the strut to deflect to a second angle in which the first end is disposed further from the downstream end of the frame assembly than is the first end in the compressed state of the frame assembly.
In an embodiment, the leg frame may be structured such that each leg of the plurality of legs is coupled to two struts of the plurality of struts, and two struts of the plurality of struts are coupled to each coupling point of the plurality of coupling points.
In an embodiment, the leg may be coupled to the valve frame via a strut, the strut having a first end that is coupled to the leg, and a second end that is coupled to the coupling point, in the compressed state of the frame assembly, being disposed at a first angle in which the first end is disposed closer to the downstream end of the frame assembly than is the second end, and being deflectable with respect to the coupling point, such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes the strut to deflect to a second angle in which the first end is disposed further from the downstream end of the frame assembly than is the first end in the compressed state of the frame assembly.
In an embodiment, the at least one leg includes at least a first leg and a second leg.
In an embodiment, the first leg and the second leg are both coupled to the valve frame at the coupling point.
In an embodiment, the first leg may be coupled to the coupling point via a respective first strut, and the second leg is coupled to the coupling point via a respective second strut.
In an embodiment, the first and second legs, the first and second struts, and the coupling point are arranged such that, in the expanded state of the frame assembly: the coupling point is disposed, circumferentially with respect to the tubular portion, between the first strut and the second strut, the first strut is disposed, circumferentially with respect to the tubular portion, between the coupling point and the first leg, and the second strut is disposed, circumferentially with respect to the tubular portion, between the coupling point and the second leg.
In an embodiment, the coupling point includes at least a first coupling point and a second coupling point.
In an embodiment, the leg is coupled to the valve frame at the first coupling point and at the second coupling point.
In an embodiment, the leg may be coupled to the first coupling point via a respective first strut, and to the second coupling point via a respective second strut.
In an embodiment, the first and second legs, the first and second struts, and the coupling point are arranged such that, in the expanded state of the frame assembly: the leg is disposed, circumferentially with respect to the tubular portion, between the first strut and the second strut, the first strut is disposed, circumferentially with respect to the tubular portion, between the leg and the first coupling point, and the second strut is disposed, circumferentially with respect to the tubular portion, between the leg and the second coupling point.
In an embodiment, in the expanded state of the frame assembly, the upstream support portion extends radially outward from the tubular portion.
In an embodiment, the expanded state of the frame assembly is a fully-expanded state of the frame assembly, the upstream support portion is expandable into an expanded state of the upstream support portion, independently of increasing the diameter of the tubular portion, and in the expanded state of the upstream support portion, the upstream support portion extends radially outward from the tubular portion.
In an embodiment, in the compressed state of the frame assembly, the upstream support portion is generally tubular, collinear with the tubular portion, and disposed around the central longitudinal axis.
In an embodiment, in the expanded state of the frame assembly, an inner region of the upstream support portion extends radially outward from the tubular portion at a first angle with respect to the tubular portion, and an outer region of the upstream support portion extends, from the inner region of the upstream support portion, further radially outward from the tubular portion at a second angle with respect to the tubular portion, the second angle being smaller than the first angle.
In accordance with an embodiment of the present invention, an apparatus for use with a native valve of a heart of a subject is provided, the apparatus including a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, and including: a valve frame, including: a tubular portion having an upstream end and a downstream end, and shaped to define a lumen therebetween, and an upstream support portion, extending from the upstream end of the tubular portion; and at least one leg, coupled to the valve frame at a coupling point, and having a tissue-engaging flange; and a valve member disposed within the lumen, and configured to facilitate one-way liquid flow through the lumen from the upstream end of the tubular portion to the downstream end of the tubular portion, and the frame assembly: has a compressed state, for percutaneous delivery to the heart, in which the tubular portion has a compressed diameter, is biased to assume an expanded state in which the tubular portion has an expanded diameter that is greater than the compressed diameter, and is configured such that reducing the diameter of the tubular portion toward the compressed diameter causes longitudinal movement of the upstream support portion away from the coupling point, and of the tissue-engaging flange toward the coupling point.
In accordance with an embodiment of the present invention, an apparatus for use with a native valve of a heart of a subject is provided, the apparatus including a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, including: a valve frame, including: a tubular portion having an upstream end and a downstream end, and shaped to define a lumen therebetween, and an upstream support portion, extending from the upstream end of the tubular portion; and at least one leg, coupled to the valve frame at a coupling point, and having a tissue-engaging flange; and a valve member disposed within the lumen, and configured to facilitate one-way liquid flow through the lumen from the upstream end of the tubular portion to the downstream end of the tubular portion, and the frame assembly: has a compressed state, for percutaneous delivery to the heart, is intracorporeally expandable into an expanded state in which a diameter of the tubular portion is greater than in the compressed state, and is configured such that increasing the diameter of the tubular portion by expanding the frame assembly toward the expanded state causes longitudinal movement of the tissue-engaging flange away from the coupling point.
In accordance with an embodiment of the present invention, an apparatus for use with a native valve of a heart of a subject is provided, the apparatus including a frame assembly, having an upstream end and a downstream end, and a central longitudinal axis therebetween, and including: an inner frame including an inner-frame tubular portion that circumscribes the central longitudinal axis, has an upstream end and a downstream end, and defines a channel therebetween, the inner frame defining a plurality of inner-frame couplings disposed circumferentially at a longitudinal location of the inner frame, an outer frame including an outer-frame tubular portion that coaxially circumscribes at least a portion of the inner-frame tubular portion, the outer frame defining a plurality of outer-frame couplings disposed circumferentially at a longitudinal location of the outer frame, and a plurality of connectors, each connector connecting a respective inner-frame coupling to a respective outer-frame coupling; a liner, disposed over at least part of the inner-frame tubular portion; and a plurality of prosthetic leaflets, coupled to the inner-frame tubular portion and disposed within the channel, and: the frame assembly: (i) is compressible by a radially-compressive force into a compressed state in which the inner frame is in a compressed state thereof and the outer frame is in a compressed state thereof, (ii) is configured, upon removal of the radially-compressive force, to automatically expand into an expanded state thereof in which the inner frame is in an expanded state thereof and the outer frame is in an expanded state thereof, in the expanded state of the frame assembly, the prosthetic leaflets are configured to facilitate one-way fluid flow, in a downstream direction, through the channel, and the connection of the inner-frame couplings to the respective outer-frame couplings is such that expansion of the frame assembly from the compressed state to the expanded state causes the inner-frame tubular portion to slide longitudinally in a downstream direction with respect to the outer-frame tubular portion.
In accordance with an embodiment of the present invention, an apparatus for use with a native valve disposed between an atrium and a ventricle of a heart of a subject is provided, the apparatus including: a tubular portion, having an upstream portion that includes an upstream end, and a downstream portion that includes a downstream end, and shaped to define a lumen between the upstream portion and the downstream portion; a plurality of prosthetic leaflets, disposed within the lumen, and arranged to provide unidirectional flow of blood from the upstream portion to the downstream portion; an annular upstream support portion: having an inner portion that extends radially outward from the upstream portion, and including one or more fabric pockets disposed circumferentially around the inner portion, each pocket of the one or more pockets having an opening that faces a downstream direction.
In an embodiment, the upstream support portion includes (i) a plurality of arms that extend radially outward from the tubular portion, and (ii) a covering, disposed over the plurality of arms, each arm has (i) a radially-inner part at the inner portion of the upstream support portion, and (ii) a radially-outer part at the outer portion of the upstream support portion, at the inner portion of the upstream support portion, the covering is closely-fitted between the radially-inner parts of the arms, and at the outer portion of the upstream support portion, the pockets are formed by the covering being loosely-fitted between the radially-outer parts of the arms.
In an embodiment, the upstream support portion includes (i) a plurality of arms that extend radially outward from the tubular portion, and (ii) a covering, disposed over the plurality of arms, each arm has (i) a radially-inner part at the inner portion of the upstream support portion, and (ii) a radially-outer part at the outer portion of the upstream support portion, the radially-outer part being more flexible than the radially-inner part.
In an embodiment, the upstream support portion includes (i) a plurality of arms that extend radially outward from the tubular portion, and (ii) a covering, disposed over the plurality of arms, each arm has (i) a radially-inner part at the inner portion of the upstream support portion, and (ii) a radially-outer part at the outer portion of the upstream support portion, at the outer portion of the upstream support portion, the pockets are formed by each arm curving to form a hook shape.
In an embodiment, each pocket may be shaped and arranged to billow in response to perivalvular flow of blood in an upstream direction.
In an embodiment, the apparatus may be configured to be transluminally delivered to the heart and implanted at the native valve by expansion of the apparatus, such that the upstream support portion is disposed in the atrium and the tubular portion extends from the upstream support portion into the ventricle, and each pocket is shaped and arranged such that perivalvular flow of blood in an upstream direction presses the pocket against tissue of the atrium.
In accordance with an embodiment of the present invention, an apparatus is provided including a plurality of prosthetic valve leaflets; and a frame assembly, including: a tubular portion defined by a repeating pattern of cells, the tubular portion extending circumferentially around a longitudinal axis so as to define a longitudinal lumen, the prosthetic valve leaflets coupled to the inner frame and disposed within the lumen; an outer frame, including a plurality of legs, distributed circumferentially around the tubular portion, each leg having a tissue-engaging flange; an upstream support portion that includes a plurality of arms that extend radially outward from the tubular portion; and a plurality of appendages, each having a first end that defines a coupling element via which the tubular portion is coupled to the outer frame, and a second end; and the frame assembly defines a plurality of hubs, distributed circumferentially around the longitudinal axis on a plane that is transverse to the longitudinal axis, each hub defined by convergence and connection of, (i) two adjacent cells of the tubular portion, (ii) an arm of the plurality of arms, and (iii) an appendage of the plurality of appendages.
In an embodiment, each hub has six radiating spokes, two of the six spokes being part of a first cell of the two adjacent cells, two of the six spokes being part of a second cell of the two adjacent cells, one of the six spokes being the arm, and one of the six spokes being the second end of the appendage.
In an embodiment, the appendages are in-plane with the tubular portion.
In an embodiment, the appendages are in-plane with the outer frame.
In accordance with an embodiment of the present invention, a method for use with a native valve of a heart of a subject is provided, the method including percutaneously advancing to heart, an implant: including a valve frame, a valve member disposed within a lumen defined by the valve frame, and at least one leg, coupled to the valve frame at a coupling point, and having an upstream end, a downstream end, and a central longitudinal axis therebetween; positioning the implant within the heart such that a tissue-engaging flange of the leg is disposed downstream of the valve, and thereafter causing the flange to protrude radially outward from the axis; subsequently, while an upstream support portion of the valve frame is disposed upstream of the valve, causing the upstream support portion to protrude radially outward from the axis, such that tissue of the valve is disposed between the upstream support portion and the flange; and subsequently, sandwiching the tissue between the upstream support portion and the flange by reducing a distance between the upstream support portion and the flange by causing longitudinal movement (i) of the upstream support portion toward the coupling point, and (ii) of the tissue-engaging flange away from the coupling point.
In an embodiment, causing the longitudinal movement (i) of the upstream support portion toward the coupling point, and (ii) of the tissue-engaging flange away from the coupling point, includes causing the longitudinal movement by increasing a diameter of the lumen.
In accordance with an embodiment of the present invention, a method for use with a native valve of a heart of a subject is provided, the method including percutaneously advancing to heart, an implant: including a valve frame, a valve member disposed within a lumen defined by the valve frame, and at least one leg, coupled to the valve frame at a coupling point, and having an upstream end, a downstream end, and a central longitudinal axis therebetween; positioning the implant within the heart such that an upstream support portion of the valve frame is disposed upstream of the valve, and thereafter causing the upstream support portion to protrude radially outward from the axis; subsequently, while a tissue-engaging flange of the leg is disposed downstream of the valve, causing the tissue-engaging flange to protrude radially outward from the axis, such that tissue of the valve is disposed between the upstream support portion and the flange; and subsequently, sandwiching the tissue between the upstream support portion and the flange by reducing a distance between the upstream support portion and the flange by causing longitudinal movement (i) of the upstream support portion toward the coupling point, and (ii) of the tissue-engaging flange away from the coupling point.
In an embodiment, causing the longitudinal movement (i) of the upstream support portion toward the coupling point, and (ii) of the tissue-engaging flange away from the coupling point, includes causing the longitudinal movement by increasing a diameter of the lumen.
In accordance with an embodiment of the present invention, a method for use with a native valve of a heart of a subject is provided, the method including: percutaneously advancing an implant to the heart, the implant having an upstream end, a downstream end, and a central longitudinal axis therebetween, and including a tubular portion, an upstream support portion, and a plurality of tissue-engaging flanges; positioning the implant within the heart such that the upstream support portion is disposed upstream of the valve, positioning the implant within the heart such that the tissue-engaging flanges are disposed downstream of the valve, without increasing a diameter of the tubular portion: causing the upstream support portion to extend radially outward from the axis so as to have a first support-portion span, and causing the flanges to extend radially outward from the axis so as to have a first flange span; and subsequently, causing the upstream support portion and the flanges move toward each other by at least 5 mm by increasing a diameter of the tubular portion such that: the upstream support portion extends radially outward so as to have a second support-portion span, the first support-portion span being at least 40 percent as great as the second support-portion span, and the flanges extend radially outward so as to have a second flange span, the first flange span being at least 30 percent as great as the second flange span.
There is further provided, in accordance with an application of the present invention, a method for use with a native valve of a heart of a subject, the method including: percutaneously advancing an implant to the heart, the implant: having an upstream end, a downstream end, and a central longitudinal axis therebetween, and including a tubular portion, an upstream support portion, and a plurality of tissue-engaging flanges; positioning the implant within the heart such that the upstream support portion is disposed upstream of the valve, positioning the implant within the heart such that the tissue-engaging flanges are disposed downstream of the valve, without increasing a diameter of the tubular portion: causing the upstream support portion to extend radially outward from the axis, and causing the flanges to extend radially outward from the axis so as to have a first flange span; and subsequently, by increasing a diameter of the tubular portion: causing the upstream support portion and the flanges move toward each other by at least 5 mm, causing the upstream support portion to move further radially outward from the axis, and causing each flange of the plurality of flanges to translate radially outward so as to have a second flange span that is greater than the first flange span.
The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:
Reference is made to
In some embodiments, and as described hereinbelow, ventricular anchor support 50 is part of an outer frame 60, and frames 30 and 60 define respective coupling elements 31 and 61, which are fixed with respect to each other at coupling points 52. As illustrated in
Prosthetic valve 20 further comprises a valve member 58 (e.g., one or more prosthetic leaflets) disposed within lumen 38, and configured to facilitate one-way liquid flow through the lumen from atrial end 34 to ventricular end 36 (e.g., thereby defining the orientation of the atrial and ventricular ends of inner frame tubular portion 32).
In the radially contracted state of frame assembly 22, inner frame tubular portion 32 has a diameter d1, and in the radially expanded state, the inner frame tubular portion has a diameter d2 that is greater that diameter d1. For some embodiments, diameter d1 is 4-15 mm, (e.g., 5-11 mm) and diameter d2 is 20-50 mm, (e.g., 23-33 mm). Frame assembly 22 is configured such that increasing the diameter of inner frame tubular portion 32 (e.g., from d1 to d2) causes longitudinal movement of outer frame tissue anchor 54 away from coupling point 52. In the same way, reducing the diameter of inner frame tubular portion 32 (e.g., from d2 to d1) causes longitudinal movement of outer frame tissue anchor 54 toward coupling point 52. It is to be noted that the term “longitudinal movement” (including the specification and the claims) means movement parallel with central longitudinal axis ax1. Therefore longitudinal movement of outer frame tissue anchor 54 away from coupling point 52 means increasing a distance, measured parallel with longitudinal axis ax1, between outer frame tissue anchor 54 and coupling point 52. An example of such a configuration is described in more detail with respect to
Thus, expansion of inner frame tubular portion 32 from its radially contracted state toward its radially expanded state (i) increases a circumferential distance between each of coupling points 52 and its adjacent coupling points (e.g., between each of outer-frame coupling elements 61 and its adjacent outer-frame coupling elements) (e.g., from d8 to d9), and (ii) moves ventricular anchor support 50 in a longitudinally atrial direction with respect to the inner frame tubular portion. The term “atrial direction” may refer to a direction extending upstream from prosthetic valve 20, towards an atrium of the heart. For example, in
In some embodiments, frame assembly 22 is configured such that increasing the diameter of inner frame tubular portion 32 also causes longitudinal movement of atrial support portion 40 toward coupling point 52, e.g., as described in more detail with respect to
For some embodiments, atrial support portion 40 comprises a plurality of inner frame tissue anchors 46 that each extends radially outward from inner frame tubular portion 32 (e.g., from atrial end 34 of the inner frame tubular portion). Inner frame tissue anchors 46 are flexible. For some such embodiments, inner frame tissue anchors 46 are coupled to inner frame tubular portion 32 such that each inner frame tissue anchor may deflect independently of adjacent inner frame tissue anchors 46 during implantation (e.g., due to anatomical topography).
For some embodiments, atrial support portion 40 comprises a plurality of barbs 48 that extend out of a ventricular surface of the atrial support portion. For example, each inner frame tissue anchor 46 may comprise one or more of barbs 48. Barbs 48 press into tissue on an atrial side of the native valve (e.g., into the valve annulus), thereby inhibiting movement of prosthetic valve 20 in a ventricular direction (in addition to inhibition of movement in a ventricular direction provided by the geometry of atrial support portion 40).
One or more surfaces of frame assembly 22 are covered with a covering 23, which comprises a flexible sheet, such as a fabric, e.g., comprising polyester. In some embodiments, covering 23 covers at least part of inner frame tubular portion 32, lining an inner surface of the inner frame tubular portion, and thereby defining lumen 38.
Further, atrial support portion 40 is covered with covering 23, e.g., extending between inner frame tissue anchors 46 to form an annular shape. It is hypothesized that this reduces a likelihood of paravalvular leakage. For such embodiments, excess covering 23 may be provided between inner frame tissue anchors 46 of atrial support portion 40, so as to facilitate their independent movement. Although
Alternatively, each inner frame tissue anchor 46 may be individually covered in a sleeve of covering 23, thereby facilitating independent movement of the inner frame tissue anchors.
For some embodiments, at least a portion of ventricular anchor support 50 (e.g., outer frame tissue anchors 54 thereof) is covered with covering 23.
In some embodiments, frame assembly 22 comprises a plurality of ventricular anchor supports 50 (e.g., two or more ventricular anchor supports, e.g., 2-16 ventricular anchor supports, such as 4-12 ventricular anchor supports, such as 6-12 ventricular anchor supports), arranged circumferentially around inner frame 30 (e.g., around the outside of inner frame tubular portion 32). In some embodiments, frame assembly 22 comprises a plurality of coupling points 52 at which the ventricular anchor supports are coupled to inner frame 30.
As described in more detail hereinbelow (e.g., with reference to
For some embodiments, a plurality of (e.g., two) ventricular anchor supports 50 are coupled to each coupling point 52 via a respective plurality of (e.g., two) struts 70. For some such embodiments, frame assembly 22 is arranged such that, in the radially expanded state of the frame assembly, coupling point 52 is disposed, circumferentially with respect to inner frame tubular portion 32, between two struts 70, and each of the two struts are disposed, circumferentially with respect to the inner frame tubular portion, between the coupling point and a respective ventricular anchor support 50.
For some embodiments, frame assembly 22 comprises an outer frame 60 that circumscribes inner frame tubular portion 32, comprises (or defines) the plurality of ventricular anchoring supports 50 and the plurality of struts 70, and is coupled to inner frame 30 at the plurality of coupling points 52, such that the plurality of ventricular anchoring supports are distributed circumferentially around the inner frame tubular portion. For such embodiments, outer frame 60 comprises a ring 66 that is defined by a pattern of alternating peaks 64 and troughs 62, and that circumscribes inner frame tubular portion 32. For example, the ring may comprise struts 70, extending between the peaks and troughs. Peaks 64 are longitudinally closer to atrial end 34 of inner frame tubular portion 32 than to ventricular end 36, and troughs 62 are longitudinally closer to the ventricular end than to the atrial end. (It is to be noted that throughout this patent application, including the specification and the claims, the term “longitudinally” means with respect to longitudinal axis ax1. For example, “longitudinally closer” means closer along axis ax1 (whether positioned on axis ax1 or lateral to axis ax1), and “longitudinal movement” means a change in position along axis ax1 (which may be in additional to movement toward or away from axis ax1). Therefore, peaks 64 are closer than troughs 62 to atrial end 34, and troughs 62 are closer than peaks 64 to ventricular end 36. As illustrated in
In the embodiment shown, the peaks and troughs are defined by ring 66 having a generally zig-zag shape. However, the scope of the invention includes ring 66 having another shape that defines peaks and troughs, such as a serpentine or sinusoid shape.
For embodiments in which frame assembly 22 has a plurality of coupling points 52, the coupling points (and therefore coupling elements 31 and 61) are disposed circumferentially around the frame assembly (e.g., around axis ax1), in some embodiments on a transverse plane that is orthogonal to axis ax1. This transverse plane is illustrated by the position of section A-A in
It is to be noted that ventricular anchor support 50 is expandable into its radially expanded state (e.g., a released-anchor state) such that outer frame tissue anchor 54 extends away from axis ax1, independently of increasing the diameter of inner frame tubular portion 32 (e.g., as shown in
For some embodiments, while inner frame tubular portion 32 remains in its radially contracted state, outer frame tissue anchor 54 can extend away from axis ax1 over 40 percent (e.g., 40-80 percent, such as 40-70 percent) of the distance that it extends from the axis subsequent to the expansion of the inner frame tubular portion. For example, for embodiments in which prosthetic valve 20 comprises a outer frame tissue anchor 54 on opposing sides of the prosthetic valve, a span d15 of the outer frame tissue anchors while inner frame tubular portion 32 is in its radially contracted state may be at least 40 percent (e.g., 40-80 percent, such as 40-70 percent) as great as a span d16 of the outer frame tissue anchors subsequent to the expansion of the inner frame tubular portion. For some embodiments, span d15 is greater than 15 mm and/or less than 50 mm (e.g., 20-30 mm). For some embodiments, span d16 is greater than 30 mm and/or less than 60 mm (e.g., 40-50 mm). It is to be noted that outer frame tissue anchor 54 is effectively fully radially expanded, with respect to other portions of ventricular anchor support 50 and/or with respect to inner frame tubular portion 32, before and after the expansion of the inner frame tubular portion.
Similarly, for some embodiments, while inner frame tubular portion 32 remains in its radially contracted state, atrial support portion 40 (e.g., inner frame tissue anchors 46) can extend away from axis ax1 over 30 percent (e.g., 30-70 percent) of the distance that it extends from the axis subsequent to the expansion of the inner frame tubular portion. That is, for some embodiments, a span d17 of the atrial support portion while inner frame tubular portion 32 is in its radially contracted state may be at least 30 percent (e.g., 30-70 percent) as great as a span d18 of the atrial support portion subsequent to the expansion of the inner frame tubular portion. For some embodiments, span d17 is greater than 16 mm (e.g., greater than 20 mm) and/or less than 50 mm (e.g., 30-40 mm). For some embodiments, span d18 is greater than 40 mm and/or less than 65 mm (e.g., 45-56 mm, such as 45-50 mm). It is to be noted that atrial support portion 40 is effectively fully radially expanded, with respect to inner frame tubular portion 32, before and after the expansion of the inner frame tubular portion.
It is to be noted that when inner frame tubular portion 32 is radially expanded, outer frame tissue anchors 54 translate radially outward from span d15 to span d16 (e.g., without deflecting). In some embodiments atrial support portion 40 behaves similarly (e.g., inner frame tissue anchors 46 translated radially outward from span d17 to span d18, e.g., without deflecting). That is, an orientation of each outer frame tissue anchor 54 and/or each inner frame tissue anchor 46 with respect to inner frame tubular portion 32 and/or axis ax1 is the same in the state shown in
For some embodiments, increasing the diameter of inner frame tubular portion 32 from d1 to d2 causes greater than 1 mm and/or less than 20 mm (e.g., 1-20 mm, such as 1-10 mm or 5-20 mm) of longitudinal movement of outer frame tissue anchor 54 away from coupling point 52. For some embodiments, increasing the diameter of inner frame tubular portion 32 from d1 to d2 causes greater than 1 mm and/or less than 20 mm (e.g., 1-20 mm, such as 1-10 mm or 5-20 mm) of longitudinal movement of atrial support portion 40 toward coupling point 52. For some embodiments, distance d3 is 7-30 mm. For some embodiments, distance d4 is 0-15 mm (e.g., 2-15 mm). For some embodiments, increasing the diameter of inner frame tubular portion 32 from d1 to d2 reduces the distance between the atrial support portion and outer frame tissue anchors 54 by more than 5 mm and/or less than 30 mm, such as 5-30 mm (e.g., 10-30 mm, such as 10-20 mm or 20-30 mm). For some embodiments, the difference between d3 and d4 is generally equal to the difference between d1 and d2. For some embodiments, the difference between d3 and d4 is more than 1.2 and/or less than 3 times (e.g., 1.5-2.5 times, such as about 2 times) greater than the difference between d1 and d2.
For some embodiments, outer frame tissue anchors 54 curve such that a tip of each outer frame tissue anchor 54 is disposed at a shallower angle with respect to inner region 42 of atrial support portion 40, than are portions of ventricular anchor support 50 that are closer to ventricular end 26 of frame assembly 22. For some such embodiments, a tip of each outer frame tissue anchor may be generally parallel with inner region 42. For some such embodiments, while inner frame tubular portion 32 is in its radially expanded state, a tip portion 55 of each outer frame tissue anchor 54 that extends from the tip of the outer frame tissue anchor at least 2 mm along the outer frame tissue anchor, is disposed within 2 mm of atrial support portion 40. Thus, for some embodiments, while inner frame tubular portion 32 is in its radially expanded state, for at least 5 percent (e.g., 5-8 percent, or at least 8 percent) of span 18 of atrial support portion 40, the atrial support portion is disposed within 2 mm of an outer frame tissue anchor 54.
For some embodiments, in the absence of any obstruction (such as tissue of the valve or covering 23) between outer frame tissue anchor 54 and atrial support portion 40, increasing the diameter of inner frame tubular portion 32 from d1 to d2 causes the outer frame tissue anchor 54 and the atrial support portion to move past each other (e.g., the outer frame tissue anchor 54 may move between inner frame tissue anchors 46 of the atrial support portion), such that the outer frame tissue anchor 54 is closer to the atrial end of prosthetic valve 20 than is the atrial support portion, e.g., as shown hereinbelow for frame assemblies 122 and 222, mutatis mutandis. (For embodiments in which atrial support portion 40 is covered by covering 23, outer frame tissue anchors 54 do not pass the covering. For example, in the absence of any obstruction, outer frame tissue anchors 54 may between inner frame tissue anchors 46, and press directly against covering 23.) It is hypothesized that for some embodiments this configuration applies greater force to the valve tissue being sandwiched, and thereby further facilitates anchoring of the prosthetic valve. That is, for some embodiments, distance d3 is smaller than the sum of distance d5 and a distance d14 (described with reference to
In some embodiments, in the radially expanded state of frame assembly 22, atrial support portion 40 has an inner region (e.g., an inner ring) 42 that extends radially outward at a first angle with respect to axis ax1 (and with respect to inner frame tubular portion 32), and an outer region (e.g., an outer ring) 44 that extends, from the inner region, further radially outward from the inner frame tubular portion at a second angle with respect to the inner frame tubular portion, the second angle being smaller than the first angle. For example, for some embodiments inner region 42 extends radially outward at an angle alpha_1 of 60-120 degrees (e.g., 70-110 degrees) with respect to axis ax1, and outer region 44 extends radially outward at an angle alpha_2 of 5-70 degrees (e.g., 10-60 degrees) with respect to axis ax1.
It is to be noted that angles alpha_1 and alpha_2 are measured between the respective region support portion 40, and the portion of axis ax1 that extends in an atrial direction from the level of frame assembly 22 at which the respective region begins to extend radially outward.
For some embodiments in which prosthetic valve 20 is configured to be placed at an atrioventricular valve (e.g., a mitral valve or a tricuspid valve) of the subject, region 42 is configured to be placed against the atrial surface of the annulus of the atrioventricular valve, and region 44 is configured to be placed against the walls of the atrium upstream of the valve.
For some embodiments, outer region 44 is more flexible than inner region 42. For example, and as shown, each inner frame tissue anchor 46 may have a different structure in region 44 than in region 42. It is hypothesized that the relative rigidity of region 42 provides resistance against ventricular migration of prosthetic valve 20, while the relative flexibility of region 44 facilitates conformation of atrial support portion 40 to the atrial anatomy.
For some embodiments, two or more of inner frame tissue anchors 46 are connected by a connector (not shown), reducing the flexibility, and/or the independence of movement of the connected inner frame tissue anchors relative to each other. For some embodiments, inner frame tissue anchors 46 are connected in particular sectors of atrial support portion 40, thereby making these sectors more rigid than sectors in which the inner frame tissue anchors are not connected. For example, a relatively rigid sector may be provided to be placed against the posterior portion of the mitral annulus, and a relatively flexible sector may be provided to be placed against the anterior side of the mitral annulus, so as to reduce forces applied by atrial support portion 40 on the aortic sinus.
For some embodiments, and as shown, coupling points 52 are disposed closer to ventricular end 26 of frame assembly 22 than are outer frame tissue anchors 54, or is atrial support portion 40.
As described in more detail with respect to
In some embodiments, in the radially contracted state of inner frame tubular portion 32, a ventricular end of each ventricular anchor support 50 is longitudinally closer than valve-frame coupling elements 31 to ventricular end 36, and outer frame tissue anchor 54 of each ventricular anchor support 50 is disposed longitudinally closer than the valve-frame coupling elements to atrial end 34. In some embodiments, this is also the case in the radially expanded state of inner frame tubular portion 32.
In the radially contracted state of frame assembly 22 (and in particular of inner frame tubular portion 32), each strut 70 is disposed at a first angle in which first end 72 is disposed closer than second end 74 to the ventricular end of the frame assembly. Expansion of frame assembly 22 (and in particular of inner frame tubular portion 32) toward its radially expanded state causes strut 70 to deflect to a second angle. This deflection moves first end 72 away from the ventricular end of frame assembly 22. That is, in the radially expanded state of frame assembly 22, first end 72 is further from the ventricular end of the frame assembly than it is when the frame assembly is in its radially contracted state. This movement is shown as a distance d5 between the position of end 72 in state (A) and its position in state (B). This movement causes the above-described movement of outer frame tissue anchors 54 away from coupling points 52. As shown, outer frame tissue anchors 54 move the same distance d5 in response to expansion of frame assembly 22. Since outer frame tissue anchors 54 and first end 72 (i.e., ventricular end 69) move the same distance d5 in response to expansion of frame assembly 22, the axial distance (i.e., the distance along axis ax1) between outer frame tissue anchors 54 and first end 72 (i.e., ventricular end 69) may remain constant between the radially expanded state and the radially contracted state of annular outer frame 60.
For embodiments in which outer frame 60 comprises ring 66, the pattern of alternating peaks and troughs may be described as having an amplitude longitudinally between the peaks and troughs, i.e., measured parallel with central longitudinal axis ax1 of frame assembly 22, and the transition between the radially contracted and radially expanded states may be described as follows: In the radially contracted state of frame assembly 22 (and in particular of inner frame tubular portion 32), the pattern of ring 66 has an amplitude d20. In the radially expanded state frame assembly 22 (and in particular of inner frame tubular portion 32), the pattern of ring 66 has an amplitude d21 that is lower than amplitude d20. Because (i) it is at peaks 64 that ring 66 is coupled to inner frame 30 at coupling points 52, and (ii) it is at troughs 62 that ring 66 is coupled to ventricular anchoring supports 50, this reduction in the amplitude of the pattern of ring 66 moves ventricular anchoring supports 50 (e.g., outer frame tissue anchors 54 thereof) longitudinally further from the ventricular end of the frame assembly. The magnitude of this longitudinal movement (e.g., the difference between magnitudes d20 and d21) is equal to d5.
In some embodiments, distance d5 is the same distance as the distance that outer frame tissue anchor 54 moves away from coupling point 52 during expansion of the frame assembly. That is, a distance between outer frame tissue anchor 54 and the portion of ventricular anchor support 50 that is coupled to strut 70, remains constant during expansion of the frame assembly. For some embodiments, the longitudinal movement of outer frame tissue anchor 54 away from coupling point 52 is a translational movement (e.g., a movement that does not include rotation or deflection of the outer frame tissue anchor 54).
For some embodiments, a distance d6, measured parallel to axis ax1 of frame assembly 22, between coupling point 52 and first end 72 of strut 70 while assembly 22 is in its radially contracted state, is 3-15 mm. For some embodiments, a distance d7, measured parallel to axis ax1, between coupling point 52 and first end 72 of strut 70 while assembly 22 is in its radially expanded state, is 1-5 mm (e.g., 1-4 mm).
For some embodiments, amplitude d20 is 2-10 mm (e.g., 4-7 mm). For some embodiments, amplitude d21 is 4-9 mm (e.g., 5-7 mm).
For some embodiments, and as shown, in the radially expanded state, first end 72 of strut 70 is disposed closer to the ventricular end of frame assembly 22 than is coupling point 52. For some embodiments, in the radially expanded state, first end 72 of strut 70 is disposed further from the ventricular end of frame assembly 22 than is coupling point 52.
For embodiments in which frame assembly 22 comprises a plurality of ventricular anchoring supports 50 and a plurality of coupling points 52 (e.g., for embodiments in which the frame assembly comprises annular outer frame 60) expansion of the frame assembly increases a circumferential distance between adjacent coupling points 52, and an increase in a circumferential distance between adjacent ventricular anchoring supports 50.
For some embodiments, in addition to being coupled via ring 66 (e.g., struts 70 thereof) ventricular anchoring supports 50 are also connected to each other via connectors 78. Connectors 78 allow the described movement of ventricular anchoring supports 50 during expansion of frame assembly 22, but stabilize ventricular anchoring supports 50 relative to each other while the frame assembly is in its radially expanded state. For example, connectors 78 may bend and/or deflect during expansion of the frame assembly.
Due to the configurations described herein, the distance by which outer frame tissue anchors 54 move with respect to (e.g., toward, or toward-and-beyond) atrial support portion 40 (e.g., inner frame tissue anchors 46 thereof), is greater than the reduction in the overall height of inner frame tubular portion 32 (e.g., more than 20 percent greater, such as more than 30 percent greater, such as more than 40 percent greater). That is, prosthetic valve 20 comprises: an inner frame (30) that comprises an inner frame tubular portion (32) that circumscribes a longitudinal axis (ax1) of the inner frame so as to define a lumen (38) along the axis, the inner frame tubular portion having an atrial end (34), a ventricular end (36), a longitudinal length therebetween, and a diameter (e.g., d1 or d2) transverse to the longitudinal axis; a valve member (58), coupled to the inner frame tubular portion, disposed within the lumen, and arranged to provide unidirectional atrial-to-ventricular flow of blood through the lumen; an atrial support portion (40), coupled to the inner frame tubular portion; and an annular outer frame (60), coupled to the inner frame tubular portion, and comprising an outer frame tissue anchor (54), wherein: the prosthetic valve has a first state (e.g., as shown in
As shown in the figures, inner frame 30 is coupled to outer frame 60 by coupling between (i) a valve-frame coupling element 31 defined by inner frame 30, and (ii) an outer-frame coupling element 61 defined by outer frame 60 (e.g., an outer-frame coupling element is coupled to end 74 of each strut). In some embodiments, elements 31 and 61 are fixed with respect to each other. Each coupling point 52 is thereby defined as the point at which a valve-frame coupling element and a corresponding outer-frame coupling element 61 are coupled (e.g., are fixed with respect to each other). For some embodiments, and as shown, elements 31 and 61 are eyelets configured to be coupled together by a connector, such as a pin or suture. For some embodiments, elements 31 and 61 are soldered or welded together.
In some embodiments, and as shown, valve-frame coupling elements 31 are defined by inner frame tubular portion 32, and are disposed circumferentially around central longitudinal axis ax1. Outer-frame coupling elements 61 are coupled to ring 66 (or defined by annular outer frame 60, such as by ring 66) at respective peaks 64.
As shown (e.g., in
The structural changes to frame assembly 22 (e.g., to outer frame 60 thereof) are described hereinabove as they occur during (e.g., as a result of) expansion of the frame assembly (in particular inner frame tubular portion 32 thereof). This is the natural way to describe these changes because, as described hereinbelow with respect to
For some embodiments, the fixation of peaks 64 to respective sites of inner frame tubular portion 32 is such that compression of the inner frame tubular portion from its radially expanded state toward its radially contracted state such that the respective sites of the inner frame tubular portion pull the peaks radially inward via radially-inward tension on coupling points 52: (i) reduces a circumferential distance between each of the coupling points and its adjacent coupling points (e.g., from d9 to d8), and (ii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20).
For some embodiments, the fixation of outer-frame coupling elements 61 to valve-frame coupling elements 31 is such that compression of inner frame tubular portion 32 from its radially expanded state toward its radially contracted state such that the valve-frame coupling elements pull the outer-frame coupling elements radially inward: (i) reduces a circumferential distance between each of the outer-frame coupling elements and its adjacent outer-frame coupling elements (e.g., from d9 to d8), and (ii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20).
For some embodiments, the fixation of peaks 64 to the respective sites of inner frame tubular portion 32 is such that compression of the inner frame tubular portion from its radially expanded state toward its radially contracted state (i) pulls the peaks radially inward via radially-inward pulling of the respective sites of the inner frame tubular portion on the peaks, (ii) reduces a circumferential distance between each of coupling points 52 and its adjacent coupling points (e.g., from d9 to d8), and (iii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20), without increasing radial gap d19 between inner frame 30 (e.g., inner frame tubular portion 32 thereof) and the ring by more than 1.5 mm.
For some embodiments, the fixation of outer-frame coupling elements 61 with respect to valve-frame coupling elements 31 is such that compression of inner frame tubular portion 32 from its radially expanded state toward its radially contracted state (i) pulls outer-frame coupling elements 61 radially inward via radially-inward pulling of valve-frame coupling elements 31 on outer-frame coupling elements 61, (ii) reduces a circumferential distance between each of the outer-frame coupling elements and its adjacent outer-frame coupling elements (e.g., from d9 to d8), and (iii) increases the amplitude of the pattern of ring 66 (e.g., from d21 to d20), without increasing radial gap d19 between inner frame 30 (e.g., inner frame tubular portion 32 thereof) and the ring by more than 1.5 mm.
Reference is made to
Prosthetic valve 20 is delivered, in its radially contracted state, to native valve 10 using a delivery tool 89 that is operable from outside the subject (
Subsequently, outer frame tissue anchors 54 are allowed to protrude radially outward, as described hereinabove, e.g., by releasing them from capsule 90 (
Subsequently, prosthetic valve 20 is moved upstream in an atrial direction, such that atrial support portion 40, in its radially contracted state, is disposed in an atrial direction of leaflets 12 (i.e., within atrium 6). For some embodiments, the atrial movement of prosthetic valve 20 causes outer frame tissue anchors 54 to engage leaflets 12. However, because of the relatively large distance d3 provided by prosthetic valve 20 (described hereinabove), for some embodiments it is not necessary to move the prosthetic valve so far in an atrial direction that outer frame tissue anchors 54 tightly engage leaflets 12 and/or pull the leaflets in an atrial direction of the valve annulus. Atrial support portion 40 is then allowed to expand such that it protrudes radially outward, as described hereinabove, e.g., by releasing it from capsule 90 (
In some embodiments, expansion of frame assembly 22 is inhibited by distal capsule-portion 92 (e.g., by inhibiting expansion of inner frame tubular portion 32), and/or by another portion of delivery tool 89 (e.g., a portion of the delivery tool that is disposed within lumen 38).
Subsequently, prosthetic valve 20 is allowed to expand toward its radially expanded state, such that inner frame tubular portion 32 widens to diameter d2, and the distance between atrial support portion 40 and outer frame tissue anchors 54 reduces to distance d4 (
As described hereinabove, prosthetic valve 20 is configured such that when inner frame tubular portion 32 is radially expanded, outer frame tissue anchors 54 and atrial support portion 40 move a relatively large distance toward each other. This enables distance d3 to be relatively large, while distance d4 is sufficiently small to provide effective anchoring. As also described hereinabove, prosthetic valve 20 is configured such that outer frame tissue anchors 54 and atrial support portion 40 can extend radially outward a relatively large distance while inner frame tubular portion 32 remains radially contracted. It is hypothesized that for some embodiments, these configurations (independently and/or together) facilitate effective anchoring of prosthetic valve 20, by facilitating placement of a relatively large proportion of valve tissue (e.g., leaflets 12) between the outer frame tissue anchors 54 and the atrial support portion prior to expanding inner frame tubular portion 32 and sandwiching the valve tissue.
It is further hypothesized that the relatively great radially-outward extension of outer frame tissue anchors 54 and atrial support portion 40 prior to expansion of inner frame tubular portion 32, further facilitates the anchoring/sandwiching step by reducing radially-outward pushing of the valve tissue (e.g., leaflets 12) during the expansion of the inner frame tubular portion, and thereby increasing the amount of valve tissue that is sandwiched.
It is yet further hypothesized that this configuration of prosthetic valve 20 facilitates identifying correct positioning of the prosthetic valve (i.e., with atrial support portion 40 in an atrial direction of leaflets 12 and outer frame tissue anchors 54 in a ventricular direction of the leaflets) prior to expanding inner frame tubular portion 32 and sandwiching the valve tissue.
As shown in
Reference is now made to
Reference is again made to
It is to be noted that for some embodiments, ventricular delivery of prosthetic valve 20 may be performed by expanding outer frame tissue anchors 54 first (e.g., as shown in
Reference is now made to
Reference is made to
Frame assembly 122 includes an inner frame 130 that includes an inner frame tubular portion 132 having an atrial end 134 and a ventricular end 136. One or more projections 128 may extend from ventricular end 136 of inner frame tubular portion 132. Inner frame tubular portion 132 may also include an atrial support portion 140 that may include a plurality of inner frame tissue anchors 146 extending from inner frame tubular portion 132. Inner frame tissue anchors 146 may connect to inner frame tubular portion 132 at connection locations 145, which may be situated in an intermediate portion of inner frame tubular portion 132 (that is, between atrial end 134 and ventricular end 136). Inner frame tissue anchors 146 may include inner regions 142 and outer regions 144. As depicted in
As illustrated in
Frame assembly 222 includes an inner frame 230 that includes an inner frame tubular portion 232 having an atrial end 234 and a ventricular end 236. One or more projections 228 may extend from ventricular end 236 of inner frame tubular portion 232. Inner frame tubular portion 232 may also include an atrial support portion 240 that may include a plurality of inner frame tissue anchors 246 extending from inner frame tubular portion 232. Inner frame tissue anchors 246 may connect to inner frame tubular portion 232 at connection locations 245, which may be situated in an intermediate portion of inner frame tubular portion 232 (i.e., between atrial end 234 and ventricular end 236). Inner frame tissue anchors 246 may include inner regions 242 and outer regions 244. As depicted in
As illustrated in
Whereas inner frame tissue anchors 46 of frame assembly 22 are shown as extending from atrial end 34 of inner frame tubular portion 32, inner frame tissue anchors 146 and 246 of frame assemblies 122 and 222, respectively, may extend from sites further in a ventricular direction. (This difference may also be made to frame assembly 22, mutatis mutandis.) Inner frame tubular portions 32, 132 and 232 are each defined by a repeating pattern of cells that extends around the central longitudinal axis. In some embodiments, and as shown, inner frame tubular portions 32, 132 and 232 are each defined by two stacked, tessellating rows of cells. In the radially expanded state of each inner frame tubular portion, these cells may be narrower at their atrial and ventricular extremities than midway between these extremities. For example, and as shown, the cells may be roughly diamond or astroid in shape. In frame assembly 22, each inner frame tissue anchor 46 is attached to and extends from a site 35 that is at the atrial extremity of cells of the atrial row. In contrast, in frame assemblies 122 and 222, each inner frame tissue anchor 146 or 246 is attached to and extends from a site 135 (assembly 122) or 235 (assembly 222) that is at the connection between two adjacent cells of the atrial row (alternatively described as being at the atrial extremity of cells of the ventricular row).
It is hypothesized by the inventors that this lower position of the inner frame tissue anchors, while maintaining the length of the lumen of the inner frame tubular portion, advantageously reduces the distance that the inner frame tubular portion (i.e., the ventricular end thereof) extends into the ventricle of the subject, and thereby reduces a likelihood of inhibiting blood flow out of the ventricle through the left ventricular outflow tract. It is further hypothesized that this position of the inner frame tissue anchors reduces radial compression of the inner frame tubular portion by movement of the heart, due to greater rigidity of the inner frame tubular portion at sites 135 and 235 (which is supported by two adjacent cells) than at site 35 (which is supported by only one cell).
As illustrated in
As depicted in
As shown, in the radially expanded state of frame assemblies 22, 122, and 222, the ventricular anchoring supports (50, 150, and 250, respectively) (and thus outer frame tissue anchors 54, 154, 254) are circumferentially staggered with the inner frame tissue anchors (46, 146, and 246, respectively). This may allow the ventricular anchoring supports 50 to move in an atrial direction between the inner frame tissue anchors during expansion of the inner frame tubular portion (32, 132 and 232, respectively), facilitating application of greater sandwiching force on tissue of the native valve. The lower position of the inner frame tissue anchors of assemblies 122 and 222 includes circumferentially shifting the position of the inner frame tissue anchors by the width of half a cell. In order to maintain the circumferential staggering of the inner frame tissue anchors 46, 146, 246 and outer frame tissue anchors 54, 154, 254, rings 166 and 266 (and thereby ventricular anchoring supports 150 and 250) are circumferentially shifted correspondingly. As a result, whereas the peaks of ring 66 generally align with connections between adjacent cells of the ventricular row of cells of inner frame tubular portion 32 (and are fixed to these sites), the peaks of rings 166 and 266 are generally aligned midway between these sites (i.e., at spaces of the cellular structure of the inner frame tubular portion). An appendages 168 (for assembly 122) or 268 (for assembly 222) facilitate fixing of the peak with respect to the tubular structure.
For assembly 122, appendages 168 are defined by inner frame 130 (e.g., by inner frame tubular portion 132 thereof) and extend (in a ventricular direction) to the peaks of ring 166, to which they are fixed. For example, each appendage 168 may define a valve-frame coupling element 131 that is fixed to a respective outer-frame coupling element 161 defined by outer frame 260. In some embodiments, appendages 168 extend from sites 135. In some embodiments, appendages 168 are integral with inner frame tubular portion 132 and/or in-plane with the inner frame tubular portion (e.g., are part of its tubular shape). As illustrated in
For assembly 222, appendages 268 are defined by outer frame 260, and extend (e.g., in an atrial direction) from the peaks of ring 266. In some embodiments, appendages 268 extend to sites 235, to which they are fixed. For example, each appendage 268 may define an outer frame coupling element 261 that is fixed to a respective inner frame coupling element 231 defined by inner frame 230 (e.g., by inner frame tubular portion 232 thereof). In some embodiments, appendages 268 are integral with outer frame 260 and/or in-plane with adjacent portions of outer frame 260, such as ring 266.
Therefore, frame assembly 122 defines a hub at site 135, and frame assembly 222 defines a hub at site 235. For some embodiments, apparatus therefore comprises: a plurality of prosthetic valve leaflets; and a frame assembly, comprising: an inner frame tubular portion (132 or 232) defined by a repeating pattern of cells, the inner frame tubular portion extending circumferentially around longitudinal axis ax1 so as to define a longitudinal lumen, the prosthetic valve leaflets coupled to the inner frame and disposed within the lumen; an outer frame (160 or 260), comprising a plurality of ventricular anchoring supports (150 or 250), distributed circumferentially around the inner frame tubular portion, each support having an outer frame tissue anchor (154 or 254); an atrial support portion (140 or 240) that comprises a plurality of inner frame tissue anchors (146 or 246) that extend radially outward from the inner frame tubular portion; and a plurality of appendages (168 or 268), each having a first end that defines a coupling element (161 or 261) via which the inner frame tubular portion is coupled to the outer frame, and a second end; wherein the frame assembly defines a plurality of hubs (135 or 235), distributed circumferentially around the longitudinal axis on a plane that is transverse to longitudinal axis ax1, each hub defined by convergence and connection of, (i) two adjacent cells of the inner frame tubular portion, (ii) an inner frame tissue anchor of the plurality of inner frame tissue anchors, and (iii) an appendage of the plurality of appendages.
Reference is made to
Frame assembly 122 comprises (i) an inner frame 330 that comprises an inner frame tubular portion 332 and an atrial support portion 340 that comprises a plurality of inner frame tissue anchors 346, and (ii) an outer frame 360 that circumscribes the inner frame, and comprises a plurality of ventricular anchoring supports 350 that each comprise an outer frame tissue anchor 354. In some embodiments, outer frame 360 comprises a ring 366 to which ventricular anchoring supports 350 are coupled. Ring 366 is defined by a pattern of alternating peaks and troughs, the peaks being fixed to frame 330 at respective coupling points 352, e.g., as described hereinabove for frame assembly 22 and/or frame assembly 122, mutatis mutandis.
Frame assembly 322 comprises an annular atrial support portion 340 that has an inner portion 342 that extends radially outward from the atrial portion (e.g., the atrial end) of inner frame tubular portion 332. Atrial support portion 340 further comprises one or more fabric pockets 344 disposed circumferentially around inner portion 342, each pocket of the one or more pockets having an opening that faces a ventricular direction (i.e., generally toward the ventricular end of prosthetic valve 320). In the figures, atrial support portion 340 has a single toroidal pocket 344 that extends circumferentially around inner portion 342.
In some embodiments, a covering 323 (e.g., similar to covering 23, described hereinabove, mutatis mutandis) is disposed over inner frame tissue anchors 346, thereby forming pocket 344. Further in some embodiments, inner frame tissue anchors 346 are shaped to form pocket 344 from covering 323. For example, and as shown, inner frame tissue anchors 346 may curve to form a hook-shape.
For some embodiments, portion 340 has a plurality of separate pockets 344, e.g., separated at inner frame tissue anchors 346. For some such embodiments, covering 323 is loosely-fitted (e.g., baggy) between radially-outward parts of inner frame tissue anchors 346, e.g., compared to inner portion 342, in which the covering is more closely-fitted between radially-inward parts of the inner frame tissue anchors.
Pocket(s) 344 may be used in combination with any of the prosthetic valves described herein, mutatis mutandis.
Reference is again made to
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
This application is a continuation of U.S. patent application Ser. No. 16/730,090, filed Dec. 30, 2019, which is a continuation of U.S. patent application Ser. No. 16/507,357, filed Jul. 10, 2019, which issued as U.S. Pat. No. 10,524,903 on Jan. 7, 2020, which is a continuation of U.S. patent application Ser. No. 15/978,494, filed May 14, 2018, which issued as U.S. Pat. No. 10,357,360 on Jul. 23, 2019, which is a continuation of U.S. patent application Ser. No. 15/541,783, filed Jul. 6, 2017, which issued as U.S. Pat. No. 9,974,651 on May 22, 2018, which is a U.S. national stage entry under 35 U.S.C. § 371 of International Application No. PCT/IL2016/050125, filed Feb. 3, 2016, which claims priority from U.S. Provisional Patent Application No. 62/112,343, filed Feb. 5, 2015, all of which are hereby incorporated by reference in their entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3874388 | King et al. | Apr 1975 | A |
| 4222126 | Boretos et al. | Sep 1980 | A |
| 4261342 | Aranguren | Apr 1981 | A |
| 4275469 | Gabbay | Jun 1981 | A |
| 4340091 | Skelton et al. | Jul 1982 | A |
| 4423525 | Vallana et al. | Jan 1984 | A |
| 4853986 | Allen | Aug 1989 | A |
| 4892541 | Alonso | Jan 1990 | A |
| 4972494 | White et al. | Nov 1990 | A |
| 4994077 | Dobben | Feb 1991 | A |
| 5078739 | Martin | Jan 1992 | A |
| 5108420 | Marks | Apr 1992 | A |
| 5314473 | Godin | May 1994 | A |
| 5332402 | Teitelbaum | Jul 1994 | A |
| 5397351 | Pavcnik et al. | Mar 1995 | A |
| 5405378 | Strecker | Apr 1995 | A |
| 5443500 | Sigwart | Aug 1995 | A |
| 5473812 | Morris et al. | Dec 1995 | A |
| 5607444 | Lam | Mar 1997 | A |
| 5607470 | Milo | Mar 1997 | A |
| 5647857 | Anderson et al. | Jul 1997 | A |
| 5702397 | Goble et al. | Dec 1997 | A |
| 5713948 | Uflacker | Feb 1998 | A |
| 5716417 | Girard et al. | Feb 1998 | A |
| 5741297 | Simon | Apr 1998 | A |
| 5765682 | Bley et al. | Jun 1998 | A |
| 5776140 | Cottone | Jul 1998 | A |
| 5868777 | Lam | Feb 1999 | A |
| 5873906 | Lau et al. | Feb 1999 | A |
| 5954766 | Zadno-Azizi et al. | Sep 1999 | A |
| 5957949 | Leonhardt et al. | Sep 1999 | A |
| 5961549 | Nguyen et al. | Oct 1999 | A |
| 5980565 | Jayaraman | Nov 1999 | A |
| 6010530 | Goicoechea | Jan 2000 | A |
| 6019787 | Richard et al. | Feb 2000 | A |
| 6042607 | Williamson, IV | Mar 2000 | A |
| 6059827 | Fenton | May 2000 | A |
| 6074417 | Peredo | Jun 2000 | A |
| 6113612 | Swanson et al. | Sep 2000 | A |
| 6120534 | Ruiz | Sep 2000 | A |
| 6126686 | Badylak et al. | Oct 2000 | A |
| 6152937 | Peterson et al. | Nov 2000 | A |
| 6165183 | Kuehn et al. | Dec 2000 | A |
| 6165210 | Lau et al. | Dec 2000 | A |
| 6187020 | Zegdi et al. | Feb 2001 | B1 |
| 6193745 | Fogarty et al. | Feb 2001 | B1 |
| 6254609 | Vrba et al. | Jul 2001 | B1 |
| 6264700 | Kilcoyne et al. | Jul 2001 | B1 |
| 6287339 | Vazquez et al. | Sep 2001 | B1 |
| 6312465 | Griffin et al. | Nov 2001 | B1 |
| 6332893 | Mortier et al. | Dec 2001 | B1 |
| 6334873 | Lane et al. | Jan 2002 | B1 |
| 6346074 | Roth | Feb 2002 | B1 |
| 6350278 | Lenker et al. | Feb 2002 | B1 |
| 6352561 | Leopold et al. | Mar 2002 | B1 |
| 6391036 | Berg et al. | May 2002 | B1 |
| 6402780 | Williamson, IV | Jun 2002 | B2 |
| 6409755 | Vrba | Jun 2002 | B1 |
| 6419696 | Ortiz et al. | Jul 2002 | B1 |
| 6428550 | Vargas et al. | Aug 2002 | B1 |
| 6440164 | Dimatteo et al. | Aug 2002 | B1 |
| 6454799 | Schreck | Sep 2002 | B1 |
| 6458153 | Bailey et al. | Oct 2002 | B1 |
| 6482228 | Norred | Nov 2002 | B1 |
| 6511491 | Grudem et al. | Jan 2003 | B2 |
| 6530952 | Vesely | Mar 2003 | B2 |
| 6540782 | Snyders | Apr 2003 | B1 |
| 6551350 | Thornton et al. | Apr 2003 | B1 |
| 6558396 | Inoue | May 2003 | B1 |
| 6558418 | Carpentier et al. | May 2003 | B2 |
| 6569196 | Vesely | May 2003 | B1 |
| 6602263 | Swanson et al. | Aug 2003 | B1 |
| 6616675 | Evard et al. | Sep 2003 | B1 |
| 6652556 | VanTessel et al. | Nov 2003 | B1 |
| 6669724 | Park et al. | Dec 2003 | B2 |
| 6682558 | Tu et al. | Jan 2004 | B2 |
| 6699256 | Logan et al. | Mar 2004 | B1 |
| 6716244 | Klaco | Apr 2004 | B2 |
| 6719781 | Kim | Apr 2004 | B1 |
| 6719788 | Cox | Apr 2004 | B2 |
| 6730118 | Spenser et al. | May 2004 | B2 |
| 6733525 | Yang et al. | May 2004 | B2 |
| 6752813 | Goldfarb et al. | Jun 2004 | B2 |
| 6755857 | Peterson et al. | Jun 2004 | B2 |
| 6764518 | Godin | Jul 2004 | B2 |
| 6767362 | Schreck | Jul 2004 | B2 |
| 6797002 | Spence et al. | Sep 2004 | B2 |
| 6821297 | Snyders | Nov 2004 | B2 |
| 6830585 | Artof et al. | Dec 2004 | B1 |
| 6830638 | Boylan et al. | Dec 2004 | B2 |
| 6893460 | Spenser et al. | May 2005 | B2 |
| 6926715 | Hauck et al. | Aug 2005 | B1 |
| 6960217 | Bolduc | Nov 2005 | B2 |
| 6964684 | Ortiz et al. | Nov 2005 | B2 |
| 6974476 | McGuckin et al. | Dec 2005 | B2 |
| 7011681 | Vesely | Mar 2006 | B2 |
| 7018406 | Seguin et al. | Mar 2006 | B2 |
| 7041132 | Quijano et al. | May 2006 | B2 |
| 7074236 | Rabkin et al. | Jul 2006 | B2 |
| 7077861 | Spence | Jul 2006 | B2 |
| 7101395 | Tremulis et al. | Sep 2006 | B2 |
| 7101396 | Artof et al. | Sep 2006 | B2 |
| 7137184 | Schreck | Nov 2006 | B2 |
| 7172625 | Shu et al. | Feb 2007 | B2 |
| 7175656 | Khairkhahan | Feb 2007 | B2 |
| 7198646 | Figulla et al. | Apr 2007 | B2 |
| 7201772 | Schwammenthal | Apr 2007 | B2 |
| 7226467 | Lucatero et al. | Jun 2007 | B2 |
| 7226477 | Cox | Jun 2007 | B2 |
| 7261686 | Couvillon, Jr. | Aug 2007 | B2 |
| 7288097 | Séguin | Oct 2007 | B2 |
| 7288111 | Holloway et al. | Oct 2007 | B1 |
| 7316716 | Egan | Jan 2008 | B2 |
| 7329279 | Haug et al. | Feb 2008 | B2 |
| 7335213 | Hyde et al. | Feb 2008 | B1 |
| 7351256 | Hojeibane et al. | Apr 2008 | B2 |
| 7374573 | Gabbay | May 2008 | B2 |
| 7377938 | Sarac et al. | May 2008 | B2 |
| 7381218 | Schreck | Jun 2008 | B2 |
| 7381219 | Salahieh et al. | Jun 2008 | B2 |
| 7404824 | Webler et al. | Jul 2008 | B1 |
| 7422603 | Lane | Sep 2008 | B2 |
| 7429269 | Schwammenthal | Sep 2008 | B2 |
| 7442204 | Schwammenthal | Oct 2008 | B2 |
| 7445630 | Lashinski et al. | Nov 2008 | B2 |
| 7455677 | Vargas et al. | Nov 2008 | B2 |
| 7455688 | Furst et al. | Nov 2008 | B2 |
| 7462162 | Phan et al. | Dec 2008 | B2 |
| 7481838 | Carpentier et al. | Jan 2009 | B2 |
| 7510575 | Spenser et al. | Mar 2009 | B2 |
| 7513909 | Lane et al. | Apr 2009 | B2 |
| 7524331 | Birdsall | Apr 2009 | B2 |
| 7527646 | Rahdert et al. | May 2009 | B2 |
| 7556632 | Zadno | Jul 2009 | B2 |
| 7556646 | Yang et al. | Jul 2009 | B2 |
| 7563267 | Goldfarb et al. | Jul 2009 | B2 |
| 7563273 | Goldfarb et al. | Jul 2009 | B2 |
| 7582111 | Krolik et al. | Sep 2009 | B2 |
| 7585321 | Cribier | Sep 2009 | B2 |
| 7597711 | Drews et al. | Oct 2009 | B2 |
| 7608091 | Goldfarb et al. | Oct 2009 | B2 |
| 7611534 | Kapadia et al. | Nov 2009 | B2 |
| 7621948 | Herrmann et al. | Nov 2009 | B2 |
| 7625403 | Krivoruchko | Dec 2009 | B2 |
| 7632302 | Vreeman et al. | Dec 2009 | B2 |
| 7635329 | Goldfarb et al. | Dec 2009 | B2 |
| 7648528 | Styrc | Jan 2010 | B2 |
| 7655015 | Goldfarb et al. | Feb 2010 | B2 |
| 7682380 | Thornton et al. | Mar 2010 | B2 |
| 7708775 | Rowe et al. | May 2010 | B2 |
| 7717952 | Case et al. | May 2010 | B2 |
| 7717955 | Lane et al. | May 2010 | B2 |
| 7731741 | Eidenschink | Jun 2010 | B2 |
| 7736388 | Goldfarb et al. | Jun 2010 | B2 |
| 7748389 | Salahieh et al. | Jul 2010 | B2 |
| 7753922 | Starksen | Jul 2010 | B2 |
| 7753949 | Lamphere et al. | Jul 2010 | B2 |
| 7758595 | Allen et al. | Jul 2010 | B2 |
| 7758632 | Hojeibane et al. | Jul 2010 | B2 |
| 7758640 | Vesely | Jul 2010 | B2 |
| 7771467 | Svensson | Aug 2010 | B2 |
| 7771469 | Liddicoat | Aug 2010 | B2 |
| 7776083 | Vesely | Aug 2010 | B2 |
| 7780726 | Seguin | Aug 2010 | B2 |
| 7785341 | Forster et al. | Aug 2010 | B2 |
| 7799069 | Bailey et al. | Sep 2010 | B2 |
| 7803181 | Furst et al. | Sep 2010 | B2 |
| 7811296 | Goldfarb et al. | Oct 2010 | B2 |
| 7811316 | Kalmann et al. | Oct 2010 | B2 |
| 7824442 | Salahieh et al. | Nov 2010 | B2 |
| 7837645 | Bessler et al. | Nov 2010 | B2 |
| 7837727 | Goetz et al. | Nov 2010 | B2 |
| 7842081 | Yadin | Nov 2010 | B2 |
| 7850725 | Vardi et al. | Dec 2010 | B2 |
| 7871432 | Bergin | Jan 2011 | B2 |
| 7871436 | Ryan et al. | Jan 2011 | B2 |
| 7887583 | Macoviak | Feb 2011 | B2 |
| 7892281 | Seguin et al. | Feb 2011 | B2 |
| 7896915 | Guyenot et al. | Mar 2011 | B2 |
| 7914544 | Nguyen et al. | Mar 2011 | B2 |
| 7914569 | Nguyen et al. | Mar 2011 | B2 |
| 7927370 | Webler et al. | Apr 2011 | B2 |
| 7942927 | Kaye et al. | May 2011 | B2 |
| 7947072 | Yang et al. | May 2011 | B2 |
| 7947075 | Goetz et al. | May 2011 | B2 |
| 7955375 | Agnew | Jun 2011 | B2 |
| 7955377 | Melsheimer | Jun 2011 | B2 |
| 7955384 | Rafiee et al. | Jun 2011 | B2 |
| 7959666 | Salahieh et al. | Jun 2011 | B2 |
| 7959672 | Salahieh et al. | Jun 2011 | B2 |
| 7967833 | Sterman et al. | Jun 2011 | B2 |
| 7967857 | Lane | Jun 2011 | B2 |
| 7981151 | Rowe | Jul 2011 | B2 |
| 7981153 | Fogarty et al. | Jul 2011 | B2 |
| 7992567 | Hirotsuka et al. | Aug 2011 | B2 |
| 7993393 | Carpentier et al. | Aug 2011 | B2 |
| 8002825 | Letac et al. | Aug 2011 | B2 |
| 8002826 | Seguin | Aug 2011 | B2 |
| 8016877 | Seguin et al. | Sep 2011 | B2 |
| 8016882 | Macoviak | Sep 2011 | B2 |
| 8021420 | Dolan | Sep 2011 | B2 |
| 8021421 | Fogarty et al. | Sep 2011 | B2 |
| 8025695 | Fogarty et al. | Sep 2011 | B2 |
| 8029518 | Goldfarb et al. | Oct 2011 | B2 |
| 8029557 | Sobrino-Serrano et al. | Oct 2011 | B2 |
| 8029564 | Johnson et al. | Oct 2011 | B2 |
| 8034104 | Carpentier et al. | Oct 2011 | B2 |
| 8038720 | Wallace et al. | Oct 2011 | B2 |
| 8043360 | McNamara et al. | Oct 2011 | B2 |
| 8048138 | Sullivan et al. | Nov 2011 | B2 |
| 8048140 | Purdy | Nov 2011 | B2 |
| 8048153 | Salahieh et al. | Nov 2011 | B2 |
| 8052592 | Goldfarb et al. | Nov 2011 | B2 |
| 8052741 | Bruszewski et al. | Nov 2011 | B2 |
| 8052749 | Salahieh et al. | Nov 2011 | B2 |
| 8057493 | Goldfarb et al. | Nov 2011 | B2 |
| 8057532 | Hoffman | Nov 2011 | B2 |
| 8057540 | Letac et al. | Nov 2011 | B2 |
| 8062355 | Figulla et al. | Nov 2011 | B2 |
| 8062359 | Marquez et al. | Nov 2011 | B2 |
| 8070708 | Rottenberg et al. | Dec 2011 | B2 |
| 8070800 | Lock et al. | Dec 2011 | B2 |
| 8070802 | Lamphere et al. | Dec 2011 | B2 |
| 8070804 | Hyde | Dec 2011 | B2 |
| 8075611 | Millwee et al. | Dec 2011 | B2 |
| 8080054 | Rowe | Dec 2011 | B2 |
| 8083793 | Lane et al. | Dec 2011 | B2 |
| D652927 | Braido et al. | Jan 2012 | S |
| D653341 | Braido et al. | Jan 2012 | S |
| 8092518 | Schreck | Jan 2012 | B2 |
| 8092520 | Quadri | Jan 2012 | B2 |
| 8092521 | Figulla et al. | Jan 2012 | B2 |
| 8105377 | Liddicoat | Jan 2012 | B2 |
| 8109996 | Stacchino et al. | Feb 2012 | B2 |
| 8118866 | Herrmann et al. | Feb 2012 | B2 |
| 8133270 | Kheradvar et al. | Mar 2012 | B2 |
| 8136218 | Millwee et al. | Mar 2012 | B2 |
| 8137398 | Tuval et al. | Mar 2012 | B2 |
| 8142492 | Forster et al. | Mar 2012 | B2 |
| 8142494 | Rahdert et al. | Mar 2012 | B2 |
| 8142496 | Berreklouw | Mar 2012 | B2 |
| 8142497 | Friedman | Mar 2012 | B2 |
| 8147504 | Ino et al. | Apr 2012 | B2 |
| 8157852 | Bloom et al. | Apr 2012 | B2 |
| 8157853 | Laske et al. | Apr 2012 | B2 |
| 8157860 | McNamara et al. | Apr 2012 | B2 |
| 8163008 | Wilson et al. | Apr 2012 | B2 |
| 8163014 | Lane et al. | Apr 2012 | B2 |
| D660433 | Braido et al. | May 2012 | S |
| D660967 | Braido et al. | May 2012 | S |
| 8167894 | Miles et al. | May 2012 | B2 |
| 8167932 | Bourang et al. | May 2012 | B2 |
| 8167935 | McGuckin, Jr. et al. | May 2012 | B2 |
| 8172896 | McNamara et al. | May 2012 | B2 |
| 8172898 | Alferness et al. | May 2012 | B2 |
| 8177836 | Lee et al. | May 2012 | B2 |
| 8182528 | Salahieh et al. | May 2012 | B2 |
| 8211169 | Lane et al. | Jul 2012 | B2 |
| 8216256 | Raschdorf, Jr. et al. | Jul 2012 | B2 |
| 8216301 | Bonhoeffer et al. | Jul 2012 | B2 |
| 8221492 | Case et al. | Jul 2012 | B2 |
| 8221493 | Boyle et al. | Jul 2012 | B2 |
| 8226710 | Nguyen et al. | Jul 2012 | B2 |
| 8231670 | Salahieh et al. | Jul 2012 | B2 |
| 8236045 | Benichou et al. | Aug 2012 | B2 |
| 8236049 | Rowe et al. | Aug 2012 | B2 |
| 8252042 | McNamara et al. | Aug 2012 | B2 |
| 8252051 | Chau et al. | Aug 2012 | B2 |
| 8252052 | Salahieh et al. | Aug 2012 | B2 |
| 8257390 | Carley et al. | Sep 2012 | B2 |
| 8267988 | Hamer et al. | Sep 2012 | B2 |
| 8277501 | Chalekian et al. | Oct 2012 | B2 |
| 8287591 | Keidar et al. | Oct 2012 | B2 |
| 8298280 | Yadin et al. | Oct 2012 | B2 |
| 8303653 | Bonhoeffer et al. | Nov 2012 | B2 |
| 8308798 | Pintor et al. | Nov 2012 | B2 |
| 8313525 | Tuval et al. | Nov 2012 | B2 |
| 8317853 | Agnew | Nov 2012 | B2 |
| 8317855 | Gregorich et al. | Nov 2012 | B2 |
| 8323335 | Rowe et al. | Dec 2012 | B2 |
| 8328868 | Paul et al. | Dec 2012 | B2 |
| 8337541 | Quadri et al. | Dec 2012 | B2 |
| 8343174 | Goldfarb et al. | Jan 2013 | B2 |
| 8343213 | Salahieh et al. | Jan 2013 | B2 |
| 8348999 | Kheradvar et al. | Jan 2013 | B2 |
| 8366767 | Zhang | Feb 2013 | B2 |
| 8372140 | Hoffman et al. | Feb 2013 | B2 |
| 8377119 | Drews et al. | Feb 2013 | B2 |
| 8398708 | Meiri et al. | Mar 2013 | B2 |
| 8403981 | Forster et al. | Mar 2013 | B2 |
| 8403983 | Quadri et al. | Mar 2013 | B2 |
| 8408214 | Spenser | Apr 2013 | B2 |
| 8414644 | Quadri et al. | Apr 2013 | B2 |
| 8425593 | Braido et al. | Apr 2013 | B2 |
| 8430934 | Das | Apr 2013 | B2 |
| 8444689 | Zhang | May 2013 | B2 |
| 8449599 | Chau et al. | May 2013 | B2 |
| 8449625 | Campbell et al. | May 2013 | B2 |
| 8454686 | Alkhatib | Jun 2013 | B2 |
| 8460365 | Haverkost et al. | Jun 2013 | B2 |
| 8474460 | Barrett et al. | Jul 2013 | B2 |
| 8500821 | Sobrino-Serrano et al. | Aug 2013 | B2 |
| 8512400 | Tran et al. | Aug 2013 | B2 |
| 8539662 | Stacchino et al. | Sep 2013 | B2 |
| 8540767 | Zhang | Sep 2013 | B2 |
| 8545544 | Spenser et al. | Oct 2013 | B2 |
| 8551160 | Figulla et al. | Oct 2013 | B2 |
| 8551161 | Dolan | Oct 2013 | B2 |
| 8562672 | Bonhoeffer et al. | Oct 2013 | B2 |
| 8568475 | Nguyen et al. | Oct 2013 | B2 |
| 8579964 | Lane et al. | Nov 2013 | B2 |
| 8579965 | Bonhoeffer et al. | Nov 2013 | B2 |
| 8585755 | Chau et al. | Nov 2013 | B2 |
| 8585756 | Bonhoeffer et al. | Nov 2013 | B2 |
| 8591460 | Wilson et al. | Nov 2013 | B2 |
| 8591570 | Revuelta et al. | Nov 2013 | B2 |
| 8623075 | Murray et al. | Jan 2014 | B2 |
| 8623080 | Fogarty et al. | Jan 2014 | B2 |
| 8628569 | Benichou et al. | Jan 2014 | B2 |
| 8628570 | Seguin | Jan 2014 | B2 |
| 8628571 | Hacohen et al. | Jan 2014 | B1 |
| 8652203 | Quadri et al. | Feb 2014 | B2 |
| 8652204 | Quill et al. | Feb 2014 | B2 |
| 8657872 | Seguin | Feb 2014 | B2 |
| 8663322 | Keranen | Mar 2014 | B2 |
| 8673020 | Sobrino-Serrano et al. | Mar 2014 | B2 |
| 8679174 | Ottma et al. | Mar 2014 | B2 |
| 8685086 | Navia et al. | Apr 2014 | B2 |
| 8696742 | Pintor et al. | Apr 2014 | B2 |
| 8728155 | Montorfano et al. | May 2014 | B2 |
| 8734507 | Keranen | May 2014 | B2 |
| 8747460 | Tuval et al. | Jun 2014 | B2 |
| 8771345 | Tuval et al. | Jul 2014 | B2 |
| 8784472 | Eidenschink | Jul 2014 | B2 |
| 8784479 | Antonsson et al. | Jul 2014 | B2 |
| 8784481 | Alkhatib et al. | Jul 2014 | B2 |
| 8795355 | Alkhatib | Aug 2014 | B2 |
| 8795356 | Quadri et al. | Aug 2014 | B2 |
| 8795357 | Yohanan et al. | Aug 2014 | B2 |
| 8801776 | House et al. | Aug 2014 | B2 |
| 8808366 | Braido et al. | Aug 2014 | B2 |
| 8840663 | Salahieh et al. | Sep 2014 | B2 |
| 8840664 | Karapetian et al. | Sep 2014 | B2 |
| 8845722 | Gabbay | Sep 2014 | B2 |
| 8852261 | White | Oct 2014 | B2 |
| 8852272 | Gross et al. | Oct 2014 | B2 |
| 8870948 | Erzberger et al. | Oct 2014 | B1 |
| 8870949 | Rowe | Oct 2014 | B2 |
| 8870950 | Hacohen | Oct 2014 | B2 |
| 8876800 | Behan | Nov 2014 | B2 |
| 8894702 | Quadri et al. | Nov 2014 | B2 |
| 8900294 | Paniagua et al. | Dec 2014 | B2 |
| 8900295 | Migliazza et al. | Dec 2014 | B2 |
| 8906083 | Obermiller et al. | Dec 2014 | B2 |
| 8911455 | Quadri et al. | Dec 2014 | B2 |
| 8911489 | Ben-Muvhar | Dec 2014 | B2 |
| 8911493 | Rowe et al. | Dec 2014 | B2 |
| 8932343 | Alkhatib et al. | Jan 2015 | B2 |
| 8945177 | Dell et al. | Feb 2015 | B2 |
| 8961595 | Alkhatib | Feb 2015 | B2 |
| 8979922 | Jayasinghe et al. | Mar 2015 | B2 |
| 8986370 | Annest | Mar 2015 | B2 |
| 8986373 | Chau et al. | Mar 2015 | B2 |
| 8986375 | Garde et al. | Mar 2015 | B2 |
| 8992599 | Thubrikar et al. | Mar 2015 | B2 |
| 8992604 | Gross et al. | Mar 2015 | B2 |
| 8992608 | Haug et al. | Mar 2015 | B2 |
| 8998982 | Richter et al. | Apr 2015 | B2 |
| 9005273 | Salahieh et al. | Apr 2015 | B2 |
| 9011468 | Ketai et al. | Apr 2015 | B2 |
| 9011527 | Li et al. | Apr 2015 | B2 |
| 9017399 | Gross et al. | Apr 2015 | B2 |
| D730520 | Braido et al. | May 2015 | S |
| D730521 | Braido et al. | May 2015 | S |
| 9023100 | Quadri et al. | May 2015 | B2 |
| 9034032 | McLean et al. | May 2015 | B2 |
| 9034033 | McLean et al. | May 2015 | B2 |
| 9039757 | McLean et al. | May 2015 | B2 |
| D732666 | Nguyen et al. | Jun 2015 | S |
| 9050188 | Schweich et al. | Jun 2015 | B2 |
| 9060858 | Thornton et al. | Jun 2015 | B2 |
| 9072603 | Tuval et al. | Jul 2015 | B2 |
| 9084676 | Chau et al. | Jul 2015 | B2 |
| 9095434 | Rowe | Aug 2015 | B2 |
| 9119719 | Zipory et al. | Sep 2015 | B2 |
| 9125738 | Figulla et al. | Sep 2015 | B2 |
| 9125740 | Morriss et al. | Sep 2015 | B2 |
| 9132006 | Spenser et al. | Sep 2015 | B2 |
| 9132009 | Hacohen et al. | Sep 2015 | B2 |
| 9138312 | Tuval et al. | Sep 2015 | B2 |
| 9155619 | Liu et al. | Oct 2015 | B2 |
| 9173659 | Bodewadt et al. | Nov 2015 | B2 |
| 9173738 | Murray et al. | Nov 2015 | B2 |
| 9180009 | Majkrzak et al. | Nov 2015 | B2 |
| 9220594 | Braido et al. | Dec 2015 | B2 |
| 9226820 | Braido et al. | Jan 2016 | B2 |
| 9226839 | Kariniemi et al. | Jan 2016 | B1 |
| 9232995 | Kovalsky et al. | Jan 2016 | B2 |
| 9241790 | Lane et al. | Jan 2016 | B2 |
| 9241791 | Braido et al. | Jan 2016 | B2 |
| 9241792 | Benichou et al. | Jan 2016 | B2 |
| 9241794 | Braido et al. | Jan 2016 | B2 |
| 9248014 | Lane et al. | Feb 2016 | B2 |
| 9277994 | Miller et al. | Mar 2016 | B2 |
| 9289290 | Alkhatib et al. | Mar 2016 | B2 |
| 9289291 | Gorman et al. | Mar 2016 | B2 |
| 9295550 | Nguyen et al. | Mar 2016 | B2 |
| 9295551 | Straubinger et al. | Mar 2016 | B2 |
| 9295552 | McLean et al. | Mar 2016 | B2 |
| 9301836 | Buchbinder et al. | Apr 2016 | B2 |
| 9320591 | Bolduc | Apr 2016 | B2 |
| D755384 | Pesce et al. | May 2016 | S |
| 9326852 | Spenser | May 2016 | B2 |
| 9345573 | Nyuli et al. | May 2016 | B2 |
| 9358107 | Nguyen et al. | Jun 2016 | B2 |
| 9387078 | Gross et al. | Jul 2016 | B2 |
| 9393110 | Levi et al. | Jul 2016 | B2 |
| 9421098 | Gifford et al. | Aug 2016 | B2 |
| 9427303 | Liddy et al. | Aug 2016 | B2 |
| 9427316 | Schweich, Jr. et al. | Aug 2016 | B2 |
| 9439757 | Wallace et al. | Sep 2016 | B2 |
| 9445893 | Vaturi | Sep 2016 | B2 |
| 9463102 | Kelly | Oct 2016 | B2 |
| 9474638 | Robinson et al. | Oct 2016 | B2 |
| 9480559 | Vidlund et al. | Nov 2016 | B2 |
| 9492273 | Wallace et al. | Nov 2016 | B2 |
| 9498314 | Behan | Nov 2016 | B2 |
| 9498332 | Hacohen et al. | Nov 2016 | B2 |
| 9532870 | Cooper et al. | Jan 2017 | B2 |
| 9554897 | Lane et al. | Jan 2017 | B2 |
| 9554899 | Granada et al. | Jan 2017 | B2 |
| 9561103 | Granada et al. | Feb 2017 | B2 |
| 9566152 | Schweich et al. | Feb 2017 | B2 |
| 9572665 | Lane et al. | Feb 2017 | B2 |
| 9597182 | Straubinger et al. | Mar 2017 | B2 |
| 9629716 | Seguin | Apr 2017 | B2 |
| 9662203 | Sheahan et al. | May 2017 | B2 |
| 9681952 | Hacohen et al. | Jun 2017 | B2 |
| 9717591 | Chau et al. | Aug 2017 | B2 |
| 9743932 | Amplatz et al. | Aug 2017 | B2 |
| 9763657 | Hacohen et al. | Sep 2017 | B2 |
| 9770256 | Cohen et al. | Sep 2017 | B2 |
| D800908 | Hariton et al. | Oct 2017 | S |
| 9788941 | Hacohen | Oct 2017 | B2 |
| 9895226 | Harari et al. | Feb 2018 | B1 |
| 10010414 | Cooper et al. | Jul 2018 | B2 |
| 10076415 | Metchik et al. | Sep 2018 | B1 |
| 10105222 | Metchik et al. | Oct 2018 | B1 |
| 10111751 | Metchik et al. | Oct 2018 | B1 |
| 10123873 | Metchik et al. | Nov 2018 | B1 |
| 10130475 | Metchik et al. | Nov 2018 | B1 |
| 10136993 | Metchik et al. | Nov 2018 | B1 |
| 10149761 | Granada et al. | Dec 2018 | B2 |
| 10154906 | Granada et al. | Dec 2018 | B2 |
| 10159570 | Metchik et al. | Dec 2018 | B1 |
| 10182908 | Tubishevitz et al. | Jan 2019 | B2 |
| 10226341 | Gross et al. | Mar 2019 | B2 |
| 10231837 | Metchik et al. | Mar 2019 | B1 |
| 10238493 | Metchik et al. | Mar 2019 | B1 |
| 10245143 | Gross et al. | Apr 2019 | B2 |
| 10245144 | Metchik et al. | Apr 2019 | B1 |
| 10292816 | Raanani et al. | May 2019 | B2 |
| 10299927 | McLean et al. | May 2019 | B2 |
| 10321995 | Christianson et al. | Jun 2019 | B1 |
| 10322020 | Lam et al. | Jun 2019 | B2 |
| 10327895 | Lozonschi et al. | Jun 2019 | B2 |
| 10335278 | McLean et al. | Jul 2019 | B2 |
| 10357360 | Hariton et al. | Jul 2019 | B2 |
| 10376361 | Gross et al. | Aug 2019 | B2 |
| 10390952 | Hariton et al. | Aug 2019 | B2 |
| 10426610 | Hariton et al. | Oct 2019 | B2 |
| 10463487 | Hariton et al. | Nov 2019 | B2 |
| 10463488 | Hariton et al. | Nov 2019 | B2 |
| 10507105 | Hariton et al. | Dec 2019 | B2 |
| 10507108 | Delgado et al. | Dec 2019 | B2 |
| 10507109 | Metchik et al. | Dec 2019 | B2 |
| 10512456 | Hacohen et al. | Dec 2019 | B2 |
| 10517719 | Miller et al. | Dec 2019 | B2 |
| 10524792 | Hernandez et al. | Jan 2020 | B2 |
| 10524903 | Hariton et al. | Jan 2020 | B2 |
| 10531872 | Hacohen et al. | Jan 2020 | B2 |
| 10548731 | Lashinski et al. | Feb 2020 | B2 |
| 10575948 | Iamberger et al. | Mar 2020 | B2 |
| 10595992 | Chambers | Mar 2020 | B2 |
| 10595997 | Metchik et al. | Mar 2020 | B2 |
| 10610358 | Vidlund et al. | Apr 2020 | B2 |
| 10631871 | Goldfarb et al. | Apr 2020 | B2 |
| 10646342 | Marr et al. | May 2020 | B1 |
| 10667908 | Hariton et al. | Jun 2020 | B2 |
| 10667912 | Dixon et al. | Jun 2020 | B2 |
| 10682227 | Hariton et al. | Jun 2020 | B2 |
| 10695177 | Hariton et al. | Jun 2020 | B2 |
| 10702385 | Hacohen | Jul 2020 | B2 |
| 10722360 | Hariton et al. | Jul 2020 | B2 |
| 10758342 | Chau et al. | Sep 2020 | B2 |
| 10758344 | Hariton et al. | Sep 2020 | B2 |
| 10799345 | Hariton et al. | Oct 2020 | B2 |
| 10813760 | Metchik et al. | Oct 2020 | B2 |
| 10820998 | Marr et al. | Nov 2020 | B2 |
| 10842627 | Delgado et al. | Nov 2020 | B2 |
| 10849748 | Hariton et al. | Dec 2020 | B2 |
| 10856972 | Hariton et al. | Dec 2020 | B2 |
| 10856975 | Hariton et al. | Dec 2020 | B2 |
| 10856978 | Straubinger et al. | Dec 2020 | B2 |
| 10864078 | Hariton et al. | Dec 2020 | B2 |
| 10874514 | Dixon et al. | Dec 2020 | B2 |
| 10881511 | Hariton et al. | Jan 2021 | B2 |
| 10888422 | Hariton et al. | Jan 2021 | B2 |
| 10888425 | Delgado et al. | Jan 2021 | B2 |
| 10888644 | Ratz et al. | Jan 2021 | B2 |
| 10905548 | Hariton et al. | Feb 2021 | B2 |
| 10905549 | Hariton et al. | Feb 2021 | B2 |
| 10905552 | Dixon et al. | Feb 2021 | B2 |
| 10905554 | Cao | Feb 2021 | B2 |
| 10918483 | Metchik et al. | Feb 2021 | B2 |
| 10925595 | Hacohen et al. | Feb 2021 | B2 |
| 10925732 | Delgado et al. | Feb 2021 | B2 |
| 10945843 | Delgado et al. | Mar 2021 | B2 |
| 10945844 | McCann et al. | Mar 2021 | B2 |
| 10959846 | Marr et al. | Mar 2021 | B2 |
| 10973636 | Hariton et al. | Apr 2021 | B2 |
| 10993809 | McCann et al. | May 2021 | B2 |
| 11065114 | Raanani et al. | Jul 2021 | B2 |
| 11083582 | McCann et al. | Aug 2021 | B2 |
| 11147672 | McCann et al. | Oct 2021 | B2 |
| 11179240 | Delgado et al. | Nov 2021 | B2 |
| 11291545 | Hacohen | Apr 2022 | B2 |
| 11291546 | Gross et al. | Apr 2022 | B2 |
| 11291547 | Gross et al. | Apr 2022 | B2 |
| 11304806 | Hariton et al. | Apr 2022 | B2 |
| 11389297 | Franklin et al. | Jul 2022 | B2 |
| 20010005787 | Oz et al. | Jun 2001 | A1 |
| 20010021872 | Bailey et al. | Sep 2001 | A1 |
| 20010056295 | Solem | Dec 2001 | A1 |
| 20020013571 | Goldfarb et al. | Jan 2002 | A1 |
| 20020032481 | Gabbay | Mar 2002 | A1 |
| 20020099436 | Thornton et al. | Jul 2002 | A1 |
| 20020151970 | Garrison et al. | Oct 2002 | A1 |
| 20020177894 | Acosta et al. | Nov 2002 | A1 |
| 20030036791 | Bonhoeffer et al. | Feb 2003 | A1 |
| 20030050694 | Yang et al. | Mar 2003 | A1 |
| 20030060875 | Wittens | Mar 2003 | A1 |
| 20030069635 | Cartledge | Apr 2003 | A1 |
| 20030074052 | Besselink | Apr 2003 | A1 |
| 20030074059 | Nguyen et al. | Apr 2003 | A1 |
| 20030083742 | Spence et al. | May 2003 | A1 |
| 20030105519 | Fasol et al. | Jun 2003 | A1 |
| 20030158578 | Pantages et al. | Aug 2003 | A1 |
| 20040010272 | Manetakis et al. | Jan 2004 | A1 |
| 20040030382 | St. Goar et al. | Feb 2004 | A1 |
| 20040039414 | Carley et al. | Feb 2004 | A1 |
| 20040093060 | Seguin et al. | May 2004 | A1 |
| 20040122503 | Campbell et al. | Jun 2004 | A1 |
| 20040122514 | Fogarty et al. | Jun 2004 | A1 |
| 20040133267 | Lane | Jul 2004 | A1 |
| 20040143315 | Bruun et al. | Jul 2004 | A1 |
| 20040176839 | Huynh et al. | Sep 2004 | A1 |
| 20040186558 | Pavcnik et al. | Sep 2004 | A1 |
| 20040186565 | Schreck | Sep 2004 | A1 |
| 20040186566 | Hindrichs et al. | Sep 2004 | A1 |
| 20040210244 | Vargas et al. | Oct 2004 | A1 |
| 20040210304 | Seguin et al. | Oct 2004 | A1 |
| 20040220593 | Greenhalgh | Nov 2004 | A1 |
| 20040225354 | Allen et al. | Nov 2004 | A1 |
| 20040236354 | Seguin | Nov 2004 | A1 |
| 20040249433 | Freitag | Dec 2004 | A1 |
| 20040260389 | Case et al. | Dec 2004 | A1 |
| 20040260394 | Douk et al. | Dec 2004 | A1 |
| 20050004668 | Aklog et al. | Jan 2005 | A1 |
| 20050021056 | St. Goar et al. | Jan 2005 | A1 |
| 20050027348 | Case et al. | Feb 2005 | A1 |
| 20050038494 | Eidenschink | Feb 2005 | A1 |
| 20050055086 | Stobie | Mar 2005 | A1 |
| 20050075731 | Artof et al. | Apr 2005 | A1 |
| 20050080430 | Wright et al. | Apr 2005 | A1 |
| 20050080474 | Andreas et al. | Apr 2005 | A1 |
| 20050085900 | Case et al. | Apr 2005 | A1 |
| 20050137681 | Shoemaker et al. | Jun 2005 | A1 |
| 20050137686 | Salahieh et al. | Jun 2005 | A1 |
| 20050137688 | Salahieh et al. | Jun 2005 | A1 |
| 20050137689 | Salahieh et al. | Jun 2005 | A1 |
| 20050137690 | Salahieh et al. | Jun 2005 | A1 |
| 20050137691 | Salahieh et al. | Jun 2005 | A1 |
| 20050137692 | Haug et al. | Jun 2005 | A1 |
| 20050137693 | Haug et al. | Jun 2005 | A1 |
| 20050137695 | Salahieh et al. | Jun 2005 | A1 |
| 20050137697 | Salahieh et al. | Jun 2005 | A1 |
| 20050137699 | Salahieh et al. | Jun 2005 | A1 |
| 20050143809 | Salahieh et al. | Jun 2005 | A1 |
| 20050154443 | Linder et al. | Jul 2005 | A1 |
| 20050182483 | Osborne et al. | Aug 2005 | A1 |
| 20050182486 | Gabbay | Aug 2005 | A1 |
| 20050197695 | Stacchino et al. | Sep 2005 | A1 |
| 20050203549 | Realyvasquez | Sep 2005 | A1 |
| 20050203618 | Sharkawy et al. | Sep 2005 | A1 |
| 20050216079 | MaCoviak | Sep 2005 | A1 |
| 20050234508 | Cummins et al. | Oct 2005 | A1 |
| 20050240200 | Bergheim | Oct 2005 | A1 |
| 20050251251 | Cribier | Nov 2005 | A1 |
| 20050256566 | Gabbay | Nov 2005 | A1 |
| 20050267573 | Macoviak et al. | Dec 2005 | A9 |
| 20060004439 | Spenser et al. | Jan 2006 | A1 |
| 20060004469 | Sokel | Jan 2006 | A1 |
| 20060015171 | Armstrong | Jan 2006 | A1 |
| 20060020275 | Goldfarb et al. | Jan 2006 | A1 |
| 20060020327 | Lashinski et al. | Jan 2006 | A1 |
| 20060020333 | Lashinski et al. | Jan 2006 | A1 |
| 20060041189 | Vancaillie | Feb 2006 | A1 |
| 20060047297 | Case | Mar 2006 | A1 |
| 20060052867 | Revuelta et al. | Mar 2006 | A1 |
| 20060089627 | Burnett et al. | Apr 2006 | A1 |
| 20060111773 | Rittgers et al. | May 2006 | A1 |
| 20060135964 | Vesely | Jun 2006 | A1 |
| 20060161250 | Shaw | Jul 2006 | A1 |
| 20060178700 | Quinn | Aug 2006 | A1 |
| 20060178740 | Stacchino et al. | Aug 2006 | A1 |
| 20060184203 | Martin et al. | Aug 2006 | A1 |
| 20060190036 | Wendel et al. | Aug 2006 | A1 |
| 20060190038 | Carley et al. | Aug 2006 | A1 |
| 20060195183 | Navia et al. | Aug 2006 | A1 |
| 20060195184 | Lane et al. | Aug 2006 | A1 |
| 20060201519 | Frazier et al. | Sep 2006 | A1 |
| 20060212111 | Case et al. | Sep 2006 | A1 |
| 20060216404 | Seyler et al. | Sep 2006 | A1 |
| 20060229708 | Powell et al. | Oct 2006 | A1 |
| 20060241656 | Starksen et al. | Oct 2006 | A1 |
| 20060241748 | Lee et al. | Oct 2006 | A1 |
| 20060247680 | Amplatz et al. | Nov 2006 | A1 |
| 20060253191 | Salahieh et al. | Nov 2006 | A1 |
| 20060259136 | Nguyen et al. | Nov 2006 | A1 |
| 20060259137 | Artof et al. | Nov 2006 | A1 |
| 20060271166 | Thill et al. | Nov 2006 | A1 |
| 20060271171 | McQuinn et al. | Nov 2006 | A1 |
| 20060282150 | Olson et al. | Dec 2006 | A1 |
| 20060287719 | Rowe et al. | Dec 2006 | A1 |
| 20070016286 | Herrmann et al. | Jan 2007 | A1 |
| 20070016288 | Gurskis et al. | Jan 2007 | A1 |
| 20070027528 | Agnew | Feb 2007 | A1 |
| 20070027549 | Godin | Feb 2007 | A1 |
| 20070038293 | St. Goar et al. | Feb 2007 | A1 |
| 20070038295 | Case et al. | Feb 2007 | A1 |
| 20070043435 | Seguin et al. | Feb 2007 | A1 |
| 20070055340 | Pryor | Mar 2007 | A1 |
| 20070056346 | Spenser et al. | Mar 2007 | A1 |
| 20070007851 | Ryan | Apr 2007 | A1 |
| 20070112422 | Dehdashtian | May 2007 | A1 |
| 20070118151 | Davidson | May 2007 | A1 |
| 20070162103 | Case et al. | Jul 2007 | A1 |
| 20070162107 | Haug et al. | Jul 2007 | A1 |
| 20070162111 | Fukamachi et al. | Jul 2007 | A1 |
| 20070173932 | Cali et al. | Jul 2007 | A1 |
| 20070197858 | Goldfarb et al. | Aug 2007 | A1 |
| 20070198077 | Cully et al. | Aug 2007 | A1 |
| 20070198097 | Zegdi | Aug 2007 | A1 |
| 20070021381 | Newhauser et al. | Sep 2007 | A1 |
| 20070213813 | Von Segesser et al. | Sep 2007 | A1 |
| 20070219630 | Chu | Sep 2007 | A1 |
| 20070225759 | Thommen et al. | Sep 2007 | A1 |
| 20070225760 | Moszner et al. | Sep 2007 | A1 |
| 20070233186 | Meng | Oct 2007 | A1 |
| 20070233237 | Krivoruchko | Oct 2007 | A1 |
| 20070239272 | Navia et al. | Oct 2007 | A1 |
| 20070239273 | Allen | Oct 2007 | A1 |
| 20070244546 | Francis | Oct 2007 | A1 |
| 20070255400 | Parravicini et al. | Nov 2007 | A1 |
| 20080004688 | Spenser et al. | Jan 2008 | A1 |
| 20080004697 | Lichtenstein et al. | Jan 2008 | A1 |
| 20080051703 | Thornton et al. | Feb 2008 | A1 |
| 20080065011 | Marchand et al. | Mar 2008 | A1 |
| 20080065204 | Macoviak et al. | Mar 2008 | A1 |
| 20080071361 | Tuval et al. | Mar 2008 | A1 |
| 20080071363 | Tuval et al. | Mar 2008 | A1 |
| 20080071366 | Tuval et al. | Mar 2008 | A1 |
| 20080071369 | Tuval et al. | Mar 2008 | A1 |
| 20080077235 | Kirson | Mar 2008 | A1 |
| 20080082083 | Forde et al. | Apr 2008 | A1 |
| 20080082166 | Styrc et al. | Apr 2008 | A1 |
| 20080086164 | Rowe et al. | Apr 2008 | A1 |
| 20080086204 | Rankin | Apr 2008 | A1 |
| 20080091261 | Long et al. | Apr 2008 | A1 |
| 20080097595 | Gabbay | Apr 2008 | A1 |
| 20080132989 | Snow et al. | Jun 2008 | A1 |
| 20080140003 | Bei et al. | Jun 2008 | A1 |
| 20080147182 | Righini et al. | Jun 2008 | A1 |
| 20080161910 | Revuelta et al. | Jul 2008 | A1 |
| 20080167705 | Agnew | Jul 2008 | A1 |
| 20080167714 | St. Goar et al. | Jul 2008 | A1 |
| 20080188929 | Schreck | Aug 2008 | A1 |
| 20080195200 | Vidlund et al. | Aug 2008 | A1 |
| 20080200980 | Robin et al. | Aug 2008 | A1 |
| 20080208328 | Antocci et al. | Aug 2008 | A1 |
| 20080208332 | Lamphere et al. | Aug 2008 | A1 |
| 20080221672 | Lamphere et al. | Sep 2008 | A1 |
| 20080234814 | Salahieh et al. | Sep 2008 | A1 |
| 20080243245 | Thambar et al. | Oct 2008 | A1 |
| 20080255580 | Hoffman et al. | Oct 2008 | A1 |
| 20080262609 | Gross et al. | Oct 2008 | A1 |
| 20080269879 | Sathe et al. | Oct 2008 | A1 |
| 20080281411 | Berreklouw | Nov 2008 | A1 |
| 20080294234 | Hartley et al. | Nov 2008 | A1 |
| 20090005863 | Goetz et al. | Jan 2009 | A1 |
| 20090054969 | Salahieh et al. | Feb 2009 | A1 |
| 20090082844 | Zacharias et al. | Mar 2009 | A1 |
| 20090088836 | Bishop et al. | Apr 2009 | A1 |
| 20090099650 | Bolduc et al. | Apr 2009 | A1 |
| 20090112159 | Slattery et al. | Apr 2009 | A1 |
| 20090125098 | Chuter | May 2009 | A1 |
| 20090157175 | Benichou | Jun 2009 | A1 |
| 20090163934 | Raschdorf, Jr. et al. | Jun 2009 | A1 |
| 20090171363 | Chocron | Jul 2009 | A1 |
| 20090177278 | Spence | Jul 2009 | A1 |
| 20090210052 | Forster et al. | Aug 2009 | A1 |
| 20090222081 | Linder et al. | Sep 2009 | A1 |
| 20090240320 | Tuval et al. | Sep 2009 | A1 |
| 20090248143 | Laham | Oct 2009 | A1 |
| 20090259306 | Rowe | Oct 2009 | A1 |
| 20090264994 | Saadat | Oct 2009 | A1 |
| 20090276040 | Rowe et al. | Nov 2009 | A1 |
| 20090281619 | Le et al. | Nov 2009 | A1 |
| 20090287304 | Dahlgren et al. | Nov 2009 | A1 |
| 20090299449 | Styrc | Dec 2009 | A1 |
| 20090306768 | Quadri | Dec 2009 | A1 |
| 20090319037 | Rowe et al. | Dec 2009 | A1 |
| 20100022823 | Goldfarb et al. | Jan 2010 | A1 |
| 20100023117 | Yoganathan et al. | Jan 2010 | A1 |
| 20100023120 | Holecek et al. | Jan 2010 | A1 |
| 20100036479 | Hill et al. | Feb 2010 | A1 |
| 20100049313 | Alon et al. | Feb 2010 | A1 |
| 20100076548 | Konno | Mar 2010 | A1 |
| 20100100167 | Bortlein et al. | Apr 2010 | A1 |
| 20100114299 | Ben-Muvhar et al. | May 2010 | A1 |
| 20100131054 | Tuval et al. | May 2010 | A1 |
| 20100137979 | Tuval et al. | Jun 2010 | A1 |
| 20100160958 | Clark | Jun 2010 | A1 |
| 20100161036 | Pintor et al. | Jun 2010 | A1 |
| 20100161042 | Maisano et al. | Jun 2010 | A1 |
| 20100174363 | Castro | Jul 2010 | A1 |
| 20100179643 | Shalev | Jul 2010 | A1 |
| 20100179648 | Richter et al. | Jul 2010 | A1 |
| 20100179649 | Richter et al. | Jul 2010 | A1 |
| 20100185277 | Braido et al. | Jul 2010 | A1 |
| 20100217382 | Chau et al. | Aug 2010 | A1 |
| 20100222810 | DeBeer et al. | Sep 2010 | A1 |
| 20100228285 | Miles et al. | Sep 2010 | A1 |
| 20100234940 | Dolan | Sep 2010 | A1 |
| 20100249908 | Chau et al. | Sep 2010 | A1 |
| 20100249917 | Zhang | Sep 2010 | A1 |
| 20100256737 | Pollock et al. | Oct 2010 | A1 |
| 20100262232 | Annest | Oct 2010 | A1 |
| 20100280603 | Maisano et al. | Nov 2010 | A1 |
| 20100280606 | Naor | Nov 2010 | A1 |
| 20100312333 | Navia et al. | Dec 2010 | A1 |
| 20100324595 | Linder et al. | Dec 2010 | A1 |
| 20100331971 | Keranen et al. | Dec 2010 | A1 |
| 20110004227 | Goldfarb et al. | Jan 2011 | A1 |
| 20110004296 | Lutter et al. | Jan 2011 | A1 |
| 20110004299 | Navia et al. | Jan 2011 | A1 |
| 20110015729 | Jimenez et al. | Jan 2011 | A1 |
| 20110015731 | Carpentier et al. | Jan 2011 | A1 |
| 20110022165 | Oba et al. | Jan 2011 | A1 |
| 20110029072 | Gabbay | Feb 2011 | A1 |
| 20110040374 | Goetz et al. | Feb 2011 | A1 |
| 20110040375 | Letac et al. | Feb 2011 | A1 |
| 20110046662 | Moszner et al. | Feb 2011 | A1 |
| 20110054466 | Rothstein et al. | Mar 2011 | A1 |
| 20110054596 | Taylor | Mar 2011 | A1 |
| 20110054598 | Johnson | Mar 2011 | A1 |
| 20110066233 | Thornton et al. | Mar 2011 | A1 |
| 20110071626 | Wright et al. | Mar 2011 | A1 |
| 20110077730 | Fenster | Mar 2011 | A1 |
| 20110082538 | Dahlgren et al. | Apr 2011 | A1 |
| 20110087322 | Letac et al. | Apr 2011 | A1 |
| 20110093063 | Schreck | Apr 2011 | A1 |
| 20110098525 | Kermode et al. | Apr 2011 | A1 |
| 20110106247 | Miller et al. | May 2011 | A1 |
| 20110112625 | Ben-Muvhar et al. | May 2011 | A1 |
| 20110112632 | Chau et al. | May 2011 | A1 |
| 20110118830 | Liddicoat et al. | May 2011 | A1 |
| 20110125257 | Seguin et al. | May 2011 | A1 |
| 20110125258 | Centola | May 2011 | A1 |
| 20110137326 | Bachman | Jun 2011 | A1 |
| 20110137397 | Chau et al. | Jun 2011 | A1 |
| 20110137409 | Yang et al. | Jun 2011 | A1 |
| 20110137410 | Hacohen | Jun 2011 | A1 |
| 20110144742 | Madrid et al. | Jun 2011 | A1 |
| 20110166636 | Rowe | Jul 2011 | A1 |
| 20110172784 | Richter | Jul 2011 | A1 |
| 20110178597 | Navia et al. | Jul 2011 | A9 |
| 20110184510 | Maisano et al. | Jul 2011 | A1 |
| 20110190877 | Lane et al. | Aug 2011 | A1 |
| 20110190879 | Bobo et al. | Aug 2011 | A1 |
| 20110202076 | Richter | Aug 2011 | A1 |
| 20110208283 | Rust | Aug 2011 | A1 |
| 20110208293 | Tabor | Aug 2011 | A1 |
| 20110208298 | Tuval et al. | Aug 2011 | A1 |
| 20110213461 | Seguin et al. | Sep 2011 | A1 |
| 20110218619 | Benichou et al. | Sep 2011 | A1 |
| 20110218620 | Meiri et al. | Sep 2011 | A1 |
| 20110224785 | Hacohen | Sep 2011 | A1 |
| 20110238159 | Guyenot et al. | Sep 2011 | A1 |
| 20110245911 | Quill et al. | Oct 2011 | A1 |
| 20110245917 | Savage et al. | Oct 2011 | A1 |
| 20110251675 | Dwork | Oct 2011 | A1 |
| 20110251676 | Sweeney et al. | Oct 2011 | A1 |
| 20110251678 | Eidenschink et al. | Oct 2011 | A1 |
| 20110251679 | Wiemeyer et al. | Oct 2011 | A1 |
| 20110251680 | Tran et al. | Oct 2011 | A1 |
| 20110251682 | Murray, III et al. | Oct 2011 | A1 |
| 20110251683 | Tabor | Oct 2011 | A1 |
| 20110257721 | Tabor | Oct 2011 | A1 |
| 20110257729 | Spenser et al. | Oct 2011 | A1 |
| 20110257736 | Marquez et al. | Oct 2011 | A1 |
| 20110257737 | Fogarty et al. | Oct 2011 | A1 |
| 20110264191 | Rothstein | Oct 2011 | A1 |
| 20110264196 | Savage et al. | Oct 2011 | A1 |
| 20110264198 | Murray, III et al. | Oct 2011 | A1 |
| 20110264199 | Tran et al. | Oct 2011 | A1 |
| 20110264200 | Tran et al. | Oct 2011 | A1 |
| 20110264201 | Yeung | Oct 2011 | A1 |
| 20110264202 | Murray, III et al. | Oct 2011 | A1 |
| 20110264203 | Dwork et al. | Oct 2011 | A1 |
| 20110264206 | Tabor | Oct 2011 | A1 |
| 20110264208 | Duffy | Oct 2011 | A1 |
| 20110270276 | Rothstein et al. | Nov 2011 | A1 |
| 20110271967 | Mortier et al. | Nov 2011 | A1 |
| 20110282438 | Drews et al. | Nov 2011 | A1 |
| 20110282439 | Thill et al. | Nov 2011 | A1 |
| 20110282440 | Cao | Nov 2011 | A1 |
| 20110283514 | Fogarty et al. | Nov 2011 | A1 |
| 20110288634 | Tuval et al. | Nov 2011 | A1 |
| 20110295363 | Girard et al. | Dec 2011 | A1 |
| 20110301688 | Dolan | Dec 2011 | A1 |
| 20110301698 | Miller et al. | Dec 2011 | A1 |
| 20110301701 | Padala et al. | Dec 2011 | A1 |
| 20110301702 | Rust et al. | Dec 2011 | A1 |
| 20110306916 | Nitzan et al. | Dec 2011 | A1 |
| 20110307049 | Kao | Dec 2011 | A1 |
| 20110313452 | Carley et al. | Dec 2011 | A1 |
| 20110313515 | Quadri et al. | Dec 2011 | A1 |
| 20110319989 | Lane et al. | Dec 2011 | A1 |
| 20110319991 | Hariton et al. | Dec 2011 | A1 |
| 20120010694 | Lutter et al. | Jan 2012 | A1 |
| 20120016468 | Robin et al. | Jan 2012 | A1 |
| 20120022629 | Perera et al. | Jan 2012 | A1 |
| 20120022633 | Olson et al. | Jan 2012 | A1 |
| 20120022637 | Ben-Muvhar et al. | Jan 2012 | A1 |
| 20120022639 | Hacohen et al. | Jan 2012 | A1 |
| 20120022640 | Gross et al. | Jan 2012 | A1 |
| 20120035703 | Lutter et al. | Feb 2012 | A1 |
| 20120035713 | Lutter et al. | Feb 2012 | A1 |
| 20120035722 | Tuval et al. | Feb 2012 | A1 |
| 20120041547 | Duffy et al. | Feb 2012 | A1 |
| 20120041551 | Spenser et al. | Feb 2012 | A1 |
| 20120046738 | Lau et al. | Feb 2012 | A1 |
| 20120046742 | Tuval et al. | Feb 2012 | A1 |
| 20120053676 | Ku et al. | Mar 2012 | A1 |
| 20120053682 | Kovalsky et al. | Mar 2012 | A1 |
| 20120053688 | Fogarty et al. | Mar 2012 | A1 |
| 20120059454 | Millwee et al. | Mar 2012 | A1 |
| 20120059458 | Buchbinder | Mar 2012 | A1 |
| 20120065464 | Ellis et al. | Mar 2012 | A1 |
| 20120078237 | Wang et al. | Mar 2012 | A1 |
| 20120078353 | Quadri et al. | Mar 2012 | A1 |
| 20120078357 | Conklin | Mar 2012 | A1 |
| 20120083832 | Delaloye et al. | Apr 2012 | A1 |
| 20120083839 | Letac et al. | Apr 2012 | A1 |
| 20120083879 | Eberhardt et al. | Apr 2012 | A1 |
| 20120089223 | Nguyen et al. | Apr 2012 | A1 |
| 20120101570 | Tuval et al. | Apr 2012 | A1 |
| 20120101571 | Thambar et al. | Apr 2012 | A1 |
| 20120101572 | Kovalsky et al. | Apr 2012 | A1 |
| 20120123511 | Brown | May 2012 | A1 |
| 20120123529 | Levi et al. | May 2012 | A1 |
| 20120123530 | Carpentier et al. | May 2012 | A1 |
| 20120130473 | Norris et al. | May 2012 | A1 |
| 20120130474 | Buckley | May 2012 | A1 |
| 20120130475 | Shaw | May 2012 | A1 |
| 20120136434 | Carpentier et al. | May 2012 | A1 |
| 20120150218 | Sandgren et al. | Jun 2012 | A1 |
| 20120165915 | Melsheimer et al. | Jun 2012 | A1 |
| 20120165930 | Gifford, III et al. | Jun 2012 | A1 |
| 20120179244 | Schankereli et al. | Jul 2012 | A1 |
| 20120197292 | Chin-Chen et al. | Aug 2012 | A1 |
| 20120283824 | Lutter et al. | Nov 2012 | A1 |
| 20120290062 | McNamara et al. | Nov 2012 | A1 |
| 20120296360 | Norris et al. | Nov 2012 | A1 |
| 20120296418 | Bonyuet et al. | Nov 2012 | A1 |
| 20120300063 | Majkrzak et al. | Nov 2012 | A1 |
| 20120310328 | Olson et al. | Dec 2012 | A1 |
| 20120323316 | Chau et al. | Dec 2012 | A1 |
| 20120330408 | Hillukka et al. | Dec 2012 | A1 |
| 20130006347 | McHugo | Jan 2013 | A1 |
| 20130018450 | Hunt | Jan 2013 | A1 |
| 20130018458 | Yohanan et al. | Jan 2013 | A1 |
| 20130030519 | Tran et al. | Jan 2013 | A1 |
| 20130035759 | Gross et al. | Feb 2013 | A1 |
| 20130041204 | Heilman et al. | Feb 2013 | A1 |
| 20130041451 | Patterson et al. | Feb 2013 | A1 |
| 20130046373 | Cartledge et al. | Feb 2013 | A1 |
| 20130066341 | Ketai et al. | Mar 2013 | A1 |
| 20130066342 | Dell et al. | Mar 2013 | A1 |
| 20130116780 | Miller et al. | May 2013 | A1 |
| 20130123896 | Bloss et al. | May 2013 | A1 |
| 20130123900 | Eblacas et al. | May 2013 | A1 |
| 20130144381 | Quadri et al. | Jun 2013 | A1 |
| 20130150945 | Crawford et al. | Jun 2013 | A1 |
| 20130150956 | Yohanan et al. | Jun 2013 | A1 |
| 20130158647 | Norris et al. | Jun 2013 | A1 |
| 20130166017 | Cartledge et al. | Jun 2013 | A1 |
| 20130166022 | Conklin | Jun 2013 | A1 |
| 20130172978 | Vidlund et al. | Jul 2013 | A1 |
| 20130172992 | Gross et al. | Jul 2013 | A1 |
| 20130178930 | Straubinger et al. | Jul 2013 | A1 |
| 20130190861 | Chau et al. | Jul 2013 | A1 |
| 20130211501 | Buckley et al. | Aug 2013 | A1 |
| 20130245742 | Norris | Sep 2013 | A1 |
| 20130253643 | Rolando et al. | Sep 2013 | A1 |
| 20130261737 | Costello | Oct 2013 | A1 |
| 20130261738 | Clague et al. | Oct 2013 | A1 |
| 20130274870 | Lombardi et al. | Oct 2013 | A1 |
| 20130282059 | Ketai et al. | Oct 2013 | A1 |
| 20130289711 | Liddy et al. | Oct 2013 | A1 |
| 20130289740 | Liddy et al. | Oct 2013 | A1 |
| 20130297013 | Klima et al. | Nov 2013 | A1 |
| 20130304197 | Buchbinder et al. | Nov 2013 | A1 |
| 20130304200 | McLean et al. | Nov 2013 | A1 |
| 20130310928 | Morriss et al. | Nov 2013 | A1 |
| 20130325114 | McLean et al. | Dec 2013 | A1 |
| 20130331929 | Mitra et al. | Dec 2013 | A1 |
| 20140000112 | Braido et al. | Jan 2014 | A1 |
| 20140005778 | Buchbinder et al. | Jan 2014 | A1 |
| 20140018911 | Zhou et al. | Jan 2014 | A1 |
| 20140018915 | Biadillah et al. | Jan 2014 | A1 |
| 20140031928 | Murphy et al. | Jan 2014 | A1 |
| 20140046430 | Shaw | Feb 2014 | A1 |
| 20140052237 | Lane et al. | Feb 2014 | A1 |
| 20140067050 | Costello et al. | Mar 2014 | A1 |
| 20140067054 | Chau et al. | Mar 2014 | A1 |
| 20140081376 | Burkart et al. | Mar 2014 | A1 |
| 20140106951 | Brandon | Apr 2014 | A1 |
| 20140120287 | Jacoby et al. | May 2014 | A1 |
| 20140121763 | Duffy et al. | May 2014 | A1 |
| 20140135894 | Norris et al. | May 2014 | A1 |
| 20140135895 | Andress et al. | May 2014 | A1 |
| 20140142681 | Norris | May 2014 | A1 |
| 20140142688 | Duffy et al. | May 2014 | A1 |
| 20140148891 | Johnson | May 2014 | A1 |
| 20140163690 | White | Jun 2014 | A1 |
| 20140172069 | Roeder et al. | Jun 2014 | A1 |
| 20140172077 | Bruchman et al. | Jun 2014 | A1 |
| 20140172082 | Bruchman et al. | Jun 2014 | A1 |
| 20140188210 | Beard et al. | Jul 2014 | A1 |
| 20140188221 | Chung et al. | Jul 2014 | A1 |
| 20140194981 | Menk et al. | Jul 2014 | A1 |
| 20140194983 | Kovalsky et al. | Jul 2014 | A1 |
| 20140207231 | Hacohen et al. | Jul 2014 | A1 |
| 20140214157 | Bortlein et al. | Jul 2014 | A1 |
| 20140214159 | Vidlund et al. | Jul 2014 | A1 |
| 20140222136 | Geist et al. | Aug 2014 | A1 |
| 20140222142 | Kovalsky et al. | Aug 2014 | A1 |
| 20140236287 | Clague et al. | Aug 2014 | A1 |
| 20140236289 | Alkhatib | Aug 2014 | A1 |
| 20140249622 | Carmi et al. | Sep 2014 | A1 |
| 20140257461 | Robinson et al. | Sep 2014 | A1 |
| 20140257467 | Lane et al. | Sep 2014 | A1 |
| 20140257475 | Gross et al. | Sep 2014 | A1 |
| 20140257476 | Montorfano et al. | Sep 2014 | A1 |
| 20140277358 | Slazas | Sep 2014 | A1 |
| 20140277409 | Bortlein et al. | Sep 2014 | A1 |
| 20140277411 | Bortlein et al. | Sep 2014 | A1 |
| 20140277412 | Börtlein et al. | Sep 2014 | A1 |
| 20140277418 | Miller | Sep 2014 | A1 |
| 20140277422 | Ratz et al. | Sep 2014 | A1 |
| 20140277427 | Ratz et al. | Sep 2014 | A1 |
| 20140296962 | Cartledge et al. | Oct 2014 | A1 |
| 20140296969 | Tegels et al. | Oct 2014 | A1 |
| 20140324164 | Gross et al. | Oct 2014 | A1 |
| 20140331475 | Duffy et al. | Nov 2014 | A1 |
| 20140343670 | Bakis et al. | Nov 2014 | A1 |
| 20140358222 | Gorman, III et al. | Dec 2014 | A1 |
| 20140358224 | Tegels et al. | Dec 2014 | A1 |
| 20140379065 | Johnson et al. | Dec 2014 | A1 |
| 20140379074 | Spence et al. | Dec 2014 | A1 |
| 20140379076 | Vidlund et al. | Dec 2014 | A1 |
| 20150018944 | O'Connell et al. | Jan 2015 | A1 |
| 20150032205 | Matheny | Jan 2015 | A1 |
| 20150045880 | Hacohen | Feb 2015 | A1 |
| 20150045881 | Lim | Feb 2015 | A1 |
| 20150094802 | Buchbinder et al. | Apr 2015 | A1 |
| 20150119970 | Nakayama et al. | Apr 2015 | A1 |
| 20150127097 | Neumann et al. | May 2015 | A1 |
| 20150142100 | Morriss et al. | May 2015 | A1 |
| 20150142103 | Vidlund | May 2015 | A1 |
| 20150157457 | Hacohen | Jun 2015 | A1 |
| 20150157458 | Thambar et al. | Jun 2015 | A1 |
| 20150173896 | Richter et al. | Jun 2015 | A1 |
| 20150173897 | Raanani et al. | Jun 2015 | A1 |
| 20150196390 | Ma et al. | Jul 2015 | A1 |
| 20150196393 | Vidlund et al. | Jul 2015 | A1 |
| 20150216661 | Hacohen et al. | Aug 2015 | A1 |
| 20150238313 | Spence et al. | Aug 2015 | A1 |
| 20150245934 | Lombardi et al. | Sep 2015 | A1 |
| 20150250588 | Yang et al. | Sep 2015 | A1 |
| 20150272730 | Melnick et al. | Oct 2015 | A1 |
| 20150272731 | Racchini et al. | Oct 2015 | A1 |
| 20150272734 | Sheps et al. | Oct 2015 | A1 |
| 20150320556 | Levi et al. | Nov 2015 | A1 |
| 20150327994 | Morriss et al. | Nov 2015 | A1 |
| 20150328000 | Ratz et al. | Nov 2015 | A1 |
| 20150335429 | Morriss et al. | Nov 2015 | A1 |
| 20150342736 | Rabito et al. | Dec 2015 | A1 |
| 20150351903 | Morriss et al. | Dec 2015 | A1 |
| 20150351904 | Cooper et al. | Dec 2015 | A1 |
| 20150351906 | Hammer et al. | Dec 2015 | A1 |
| 20150359629 | Ganesan et al. | Dec 2015 | A1 |
| 20160030169 | Shahriari | Feb 2016 | A1 |
| 20160030171 | Quijano et al. | Feb 2016 | A1 |
| 20160089482 | Siegenthaler | Mar 2016 | A1 |
| 20160095700 | Righini | Apr 2016 | A1 |
| 20160100939 | Amstrong et al. | Apr 2016 | A1 |
| 20160106539 | Buchbinder et al. | Apr 2016 | A1 |
| 20160113765 | Ganesan et al. | Apr 2016 | A1 |
| 20160113766 | Ganesan et al. | Apr 2016 | A1 |
| 20160113768 | Ganesan et al. | Apr 2016 | A1 |
| 20160158497 | Tran et al. | Jun 2016 | A1 |
| 20160175095 | Dienno et al. | Jun 2016 | A1 |
| 20160184098 | Vaturi | Jun 2016 | A1 |
| 20160213473 | Hacohen et al. | Jul 2016 | A1 |
| 20160220367 | Barrett | Aug 2016 | A1 |
| 20160242902 | Morriss et al. | Aug 2016 | A1 |
| 20160270911 | Ganesan et al. | Sep 2016 | A1 |
| 20160296330 | Hacohen | Oct 2016 | A1 |
| 20160310268 | Oba et al. | Oct 2016 | A1 |
| 20160310274 | Gross et al. | Oct 2016 | A1 |
| 20160317301 | Quadri et al. | Nov 2016 | A1 |
| 20160317305 | Pelled et al. | Nov 2016 | A1 |
| 20160324633 | Gross et al. | Nov 2016 | A1 |
| 20160324635 | Vidlund et al. | Nov 2016 | A1 |
| 20160324640 | Gifford et al. | Nov 2016 | A1 |
| 20160331525 | Straubinger et al. | Nov 2016 | A1 |
| 20160331526 | Schweich et al. | Nov 2016 | A1 |
| 20160338706 | Rowe | Nov 2016 | A1 |
| 20160367360 | Cartledge et al. | Dec 2016 | A1 |
| 20160367368 | Vidlund et al. | Dec 2016 | A1 |
| 20160374802 | Levi et al. | Dec 2016 | A1 |
| 20170042678 | Ganesan et al. | Feb 2017 | A1 |
| 20170049435 | Sauer et al. | Feb 2017 | A1 |
| 20170056166 | Ratz et al. | Mar 2017 | A1 |
| 20170056171 | Cooper et al. | Mar 2017 | A1 |
| 20170065407 | Hacohen et al. | Mar 2017 | A1 |
| 20170065411 | Grundeman et al. | Mar 2017 | A1 |
| 20170100236 | Robertson et al. | Apr 2017 | A1 |
| 20170128205 | Tamir et al. | May 2017 | A1 |
| 20170135816 | Lashinski et al. | May 2017 | A1 |
| 20170189174 | Braido et al. | Jul 2017 | A1 |
| 20170196688 | Christianson et al. | Jul 2017 | A1 |
| 20170196692 | Kirk et al. | Jul 2017 | A1 |
| 20170209264 | Chau et al. | Jul 2017 | A1 |
| 20170216026 | Quill et al. | Aug 2017 | A1 |
| 20170224323 | Rowe et al. | Aug 2017 | A1 |
| 20170231757 | Gassler | Aug 2017 | A1 |
| 20170231759 | Geist et al. | Aug 2017 | A1 |
| 20170231760 | Lane et al. | Aug 2017 | A1 |
| 20170239048 | Goldfarb et al. | Aug 2017 | A1 |
| 20170325948 | Wallace et al. | Nov 2017 | A1 |
| 20170333183 | Backus | Nov 2017 | A1 |
| 20170333187 | Hariton et al. | Nov 2017 | A1 |
| 20180000580 | Wallace et al. | Jan 2018 | A1 |
| 20180014930 | Hariton et al. | Jan 2018 | A1 |
| 20180021129 | Peterson et al. | Jan 2018 | A1 |
| 20180028215 | Cohen | Feb 2018 | A1 |
| 20180049873 | Manash et al. | Feb 2018 | A1 |
| 20180055630 | Patel et al. | Mar 2018 | A1 |
| 20180098850 | Rafiee et al. | Apr 2018 | A1 |
| 20180116790 | Ratz et al. | May 2018 | A1 |
| 20180116843 | Schreck et al. | May 2018 | A1 |
| 20180125644 | Conklin | May 2018 | A1 |
| 20180132999 | Perouse | May 2018 | A1 |
| 20180153689 | Maimon et al. | Jun 2018 | A1 |
| 20180161159 | Lee et al. | Jun 2018 | A1 |
| 20180206983 | Noe et al. | Jul 2018 | A1 |
| 20180214263 | Rolando et al. | Aug 2018 | A1 |
| 20180243086 | Barbarino et al. | Aug 2018 | A1 |
| 20180250126 | O'Connor et al. | Sep 2018 | A1 |
| 20180250147 | Syed | Sep 2018 | A1 |
| 20180296333 | Dixon et al. | Oct 2018 | A1 |
| 20180296336 | Cooper et al. | Oct 2018 | A1 |
| 20180325671 | Abunassar et al. | Nov 2018 | A1 |
| 20180344457 | Gross et al. | Dec 2018 | A1 |
| 20180344490 | Fox et al. | Dec 2018 | A1 |
| 20180353294 | Calomeni et al. | Dec 2018 | A1 |
| 20180360457 | Ellis et al. | Dec 2018 | A1 |
| 20190000613 | Delgado et al. | Jan 2019 | A1 |
| 20190015200 | Delgado et al. | Jan 2019 | A1 |
| 20190021852 | Delgado et al. | Jan 2019 | A1 |
| 20190053896 | Adamek-Bowers et al. | Feb 2019 | A1 |
| 20190060060 | Chau et al. | Feb 2019 | A1 |
| 20190060068 | Cope et al. | Feb 2019 | A1 |
| 20190060070 | Groothuis et al. | Feb 2019 | A1 |
| 20190069997 | Ratz et al. | Mar 2019 | A1 |
| 20190083261 | Perszyk et al. | Mar 2019 | A1 |
| 20190105153 | Barash et al. | Apr 2019 | A1 |
| 20190117391 | Humair | Apr 2019 | A1 |
| 20190175339 | Vidlund | Jun 2019 | A1 |
| 20190183639 | Moore | Jun 2019 | A1 |
| 20190192295 | Spence et al. | Jun 2019 | A1 |
| 20190336280 | Naor et al. | Nov 2019 | A1 |
| 20190350701 | Adamek-Bowers et al. | Nov 2019 | A1 |
| 20190365530 | Hoang et al. | Dec 2019 | A1 |
| 20190388218 | Vidlund et al. | Dec 2019 | A1 |
| 20190388220 | Vidlund et al. | Dec 2019 | A1 |
| 20200000449 | Goldfarb et al. | Jan 2020 | A1 |
| 20200000579 | Manash et al. | Jan 2020 | A1 |
| 20200015964 | Noe et al. | Jan 2020 | A1 |
| 20200030098 | Delgado et al. | Jan 2020 | A1 |
| 20200054335 | Hernandez et al. | Feb 2020 | A1 |
| 20200060818 | Geist et al. | Feb 2020 | A1 |
| 20200113677 | McCann et al. | Apr 2020 | A1 |
| 20200113689 | McCann et al. | Apr 2020 | A1 |
| 20200113692 | McCann et al. | Apr 2020 | A1 |
| 20200138567 | Marr et al. | May 2020 | A1 |
| 20200163761 | Hariton et al. | May 2020 | A1 |
| 20200214832 | Metchik et al. | Jul 2020 | A1 |
| 20200237512 | McCann et al. | Jul 2020 | A1 |
| 20200246136 | Marr et al. | Aug 2020 | A1 |
| 20200246140 | Hariton et al. | Aug 2020 | A1 |
| 20200253600 | Darabian | Aug 2020 | A1 |
| 20200261094 | Goldfarb et al. | Aug 2020 | A1 |
| 20200315786 | Metchik et al. | Oct 2020 | A1 |
| 20200337842 | Metchik et al. | Oct 2020 | A1 |
| 20210085455 | Bateman et al. | Mar 2021 | A1 |
| 20210093449 | Hariton et al. | Apr 2021 | A1 |
| 20210106419 | Abunassar | Apr 2021 | A1 |
| 20210113331 | Quadri et al. | Apr 2021 | A1 |
| 20210137680 | Kizuka et al. | May 2021 | A1 |
| 20210259835 | Tyler, II et al. | Aug 2021 | A1 |
| 20220000612 | Hacohen | Jan 2022 | A1 |
| Number | Date | Country |
|---|---|---|
| 2822801 | Aug 2006 | CA |
| 103974674 | Aug 2014 | CN |
| 0170262 | Feb 1986 | EP |
| 1264582 | Dec 2002 | EP |
| 1264582 | Dec 2002 | EP |
| 1637092 | Mar 2006 | EP |
| 2349124 | Oct 2018 | EP |
| 358922 | Dec 2019 | EP |
| 3270825 | Apr 2020 | EP |
| 2485795 | Sep 2020 | EP |
| 1999030647 | Jun 1999 | WO |
| 2000-047139 | Aug 2000 | WO |
| 2001-062189 | Aug 2001 | WO |
| WO 2003020179 | Mar 2003 | WO |
| 03028558 | Apr 2003 | WO |
| WO 2004028399 | Apr 2004 | WO |
| 2004108191 | Dec 2004 | WO |
| WO 2006007389 | Jan 2006 | WO |
| 06054930 | May 2006 | WO |
| 2006070372 | Jul 2006 | WO |
| 2006089236 | Aug 2006 | WO |
| WO 2006086434 | Aug 2006 | WO |
| WO 2006116558 | Nov 2006 | WO |
| WO 2006128193 | Nov 2006 | WO |
| WO 2007047488 | Apr 2007 | WO |
| 2007059252 | May 2007 | WO |
| 08013915 | Jan 2008 | WO |
| WO 2008029296 | Mar 2008 | WO |
| 2008070797 | Jun 2008 | WO |
| 2008103722 | Aug 2008 | WO |
| 09033469 | Mar 2009 | WO |
| 09053497 | Apr 2009 | WO |
| 2009091509 | Jul 2009 | WO |
| WO 2009091509 | Jul 2009 | WO |
| 2010006627 | Jan 2010 | WO |
| WO 2010006627 | Jan 2010 | WO |
| WO 2010027485 | Mar 2010 | WO |
| WO 2010045297 | Apr 2010 | WO |
| WO 2010057262 | May 2010 | WO |
| 2010073246 | Jul 2010 | WO |
| 2010081033 | Jul 2010 | WO |
| 2011069048 | Jun 2011 | WO |
| WO 2011069048 | Jun 2011 | WO |
| 2011089601 | Jul 2011 | WO |
| 2011106137 | Sep 2011 | WO |
| 2011111047 | Sep 2011 | WO |
| 0187190 | Nov 2011 | WO |
| 2011137531 | Nov 2011 | WO |
| 2011-143263 | Nov 2011 | WO |
| WO 2011144351 | Nov 2011 | WO |
| 2011154942 | Dec 2011 | WO |
| 2012011108 | Jan 2012 | WO |
| 2012024428 | Feb 2012 | WO |
| 2012036740 | Mar 2012 | WO |
| WO 2012036740 | Mar 2012 | WO |
| WO 2012048035 | Apr 2012 | WO |
| 2012127309 | Sep 2012 | WO |
| 2012177942 | Dec 2012 | WO |
| 2013021374 | Feb 2013 | WO |
| 2013021375 | Feb 2013 | WO |
| 2013021384 | Feb 2013 | WO |
| WO 2013059747 | Apr 2013 | WO |
| WO 2013072496 | May 2013 | WO |
| 2013078497 | Jun 2013 | WO |
| WO 2013078497 | Jun 2013 | WO |
| WO 2013114214 | Aug 2013 | WO |
| 2013128436 | Sep 2013 | WO |
| WO 2013175468 | Nov 2013 | WO |
| 2014022124 | Feb 2014 | WO |
| 2014076696 | May 2014 | WO |
| 2014115149 | Jul 2014 | WO |
| 2014121280 | Aug 2014 | WO |
| 2014145338 | Sep 2014 | WO |
| WO 2014144937 | Sep 2014 | WO |
| WO 2014164364 | Oct 2014 | WO |
| 2015173794 | Nov 2015 | WO |
| 2016016899 | Feb 2016 | WO |
| 2016093877 | Jun 2016 | WO |
| WO 2016098104 | Jun 2016 | WO |
| 2016125160 | Aug 2016 | WO |
| WO 2016150806 | Sep 2016 | WO |
| WO 2018025260 | Feb 2018 | WO |
| WO 2018029680 | Feb 2018 | WO |
| WO 2018039631 | Mar 2018 | WO |
| WO 2018106837 | Jun 2018 | WO |
| WO 2018112429 | Jun 2018 | WO |
| WO 2018118717 | Jun 2018 | WO |
| WO 2018131042 | Jul 2018 | WO |
| WO 2018131043 | Jul 2018 | WO |
| WO 2019027507 | Feb 2019 | WO |
| WO 2019195860 | Oct 2019 | WO |
| WO 2020167677 | Aug 2020 | WO |
| 2021156866 | Aug 2021 | WO |
| 2021186424 | Sep 2021 | WO |
| Entry |
|---|
| Sündermann, Simon H. et al., Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design, 42 European Journal of Cardio-Thoracic Surgery, Jun. 27, 2012, at e48 (5 pages). |
| Symetis S.A., Clinical Investigation Plan for ACURATE Neo™ TA Delivery System, Protocol Jan. 2015, ver. 2, ClinicalTrials.gov Identifier NCT02950428, Sept. 8, 2015 (76 pages). |
| Tchetche, Didier et al., New-generation TAVI devices: description and specifications, 10 EuroIntervention (Supplement), Sep. 2014, at U90 (11 pages). |
| International Search Report dated May 30, 2016, by the European Patent Office in PCT/IL2016/050125 (6 pages). |
| Written Opinion of the International Searching Authority issued by the European Patent Office in PCT/IL2016/050125 (7 pages). |
| European Search Report dated Jun. 29, 2017, which issued during the prosecution of Applicant's European App. No. 11809374.9. |
| An Invitation to pay additional fees dated Sep. 29, 2017, which issued during the prosecution of Applicant's PCT/IL2017/050873. |
| Edwards Lifesciences Corp. v. Cardiovalve Ltd., IPR2021-00383, Exhibit 2009: Percutaneous Mitral Leaflet Repair: MitraClip Therapy for Mitral Regurgitation (Aug. 17, 2012) (8 pages). |
| Edwards Lifesciences Corp. v. Cardiovalve Ltd., IPR2021-00383, Exhibit 2010: Deposition of Dr. Ivan Vesely, Ph.D. (Sep. 27, 2021) (170 pages). |
| Edwards Lifesciences Corp. v. Cardiovalve Ltd., IPR2021-00383, Exhibit 2014: Second Declaration of Dr. Michael Sacks (Oct. 13, 2021) (28 pages). |
| Edwards Lifesciences Corp. v. Cardiovalve Ltd., IPR2021-00383, Patent Owner's Contingent Motion to Amend Under 37 C.F.R. § 42.121 (Oct. 13, 2021) (35 pages). |
| Edwards Lifesciences Corp. v. Cardiovalve Ltd., IPR2021-00383, Patent Owner's Response Pursuant to 37 C.F.R. § 42.120 (Oct. 13, 2021) (75 pages). |
| Fann, James I. et al., Beating Heart Catheter-Based Edge-to-Edge Mitral Valve Procedure in a Porcine Model: Efficacy and Healing Response, 110 Circulation, Aug. 2004, at 988 (6 pages). |
| Feldman, Ted et al., Percutaneous Mitral Repair With the MitraClip System: Safety and Midterm Durability in the Initial EVEREST Cohort, 54 J. Am. Coll. Cardiology, Aug. 2009, at 686 (9 pages). |
| Feldman, Ted et al., Percutaneous Mitral Valve Repair Using the Edge-to-Edge Technique: Six-Month Results of the EVEREST Phase I Clinical Trial, 46 J. Am. Coll. Cardiology, Dec. 2005, at 3134 (7 pages). |
| Maisano, Francesco et al., The Evolution From Surgery to Percutaneous Mitral Valve Interventions: The Role of the Edge-to-Edge Technique, 58 J. Am. Coll. Cardiology, Nov. 2011, at 2174 (9 pages). |
| An Office Action dated Oct. 23, 2017, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
| An Office Action dated Jan. 17, 2018, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
| An Office Action dated Dec. 7, 2017, which issued during the prosecution of U.S. Appl. No. 15/213,791. |
| An Office Action dated Feb. 8, 2018, which issued during the prosecution of U.S. Appl. No. 15/213,791. |
| An Office Action dated Feb. 2, 2018, which issued during the prosecution of U.S. Appl. No. 15/329,920. |
| An Office Action dated Feb. 7, 2018, which issued during the prosecution of U.S. Appl. No. 15/197,069. |
| An Invitation to pay additional fees dated Jan. 2, 2018, which issued during the prosecution of Applicant's PCT/IL2017/050849. |
| An Office Action dated Nov. 23, 2012, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| An Office Action dated Dec. 31, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
| An Office Action dated Feb. 6, 2013. which issued during the prosecution of U.S. Appl. No. 13/412,814. |
| Langer F et al., “RING plus STRING: Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation,” J Thorac Cardiovasc Surg 133:247-9, Jan. 2007. |
| Langer F et al., “RING+STRING: Successful repair technique for ischemic mitral regurgitation with severe leaflet tethering,” Circulation 120[suppl 1]: S85-S91, Sep. 2009. |
| “Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves”, J Webb et al., Circulation, Apr. 2010; 121: 1848-1857. |
| Jansen, J., Willeke, S., Reul, H. and Rum, G. (1992), Detachable Shape-Memory Sewing Ring for Heart Valves. Artificial Organs, 16:294-297. 1992 (an abstract). |
| Alexander S. Geha, et al., Replacement of degenerated mitral and aortic bioprostheses without explanation Ann Thorac Surg. Jun. 2001; 72:1509-1514. |
| An International Search Report and a Written Opinion both dated Oct. 13, 2011 which issued during the prosecution of Applicant's PCT/IL11/00231. |
| An Office Action dated Jul. 1, 2016, which issued during the prosecution of U.S. Appl. No. 14/161,921. |
| An International Search Report and a Written Opinion both dated Dec. 5, 2011, which issued during the prosecution of Applicant's PCT/IL11/00582. |
| An Office Action dated May 29, 2012, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| U.S. Appl. No. 61/555,160, filed Nov. 3, 2011. |
| U.S. Appl. No. 61/525,281, filed Aug. 19, 2011. |
| U.S. Appl. No. 61/537,276, filed Sep. 21, 2011. |
| U.S. Appl. No. 61/515,372, filed Aug. 5, 2011. |
| U.S. Appl. No. 61/492,449, filed Jun. 2, 2011. |
| U.S. Appl. No. 61/588,892, filed Jan. 20, 2012. |
| An International Search Report and a Written Opinion both dated Feb. 6, 2013, which issued during the prosecution of Applicant's PCT/IL12/00292. |
| An International Search Report and a Written Opinion both dated Feb. 6, 2013, which issued during the prosecution of Applicant's PCT/IL12/00293. |
| An Office Action dated Nov. 28, 2012, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| An Office Action dated Feb. 15, 2013, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| An Office Action dated Feb. 10, 2014, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| An Office Action dated Sep. 19, 2014, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
| An International Search Report and a Written Opinion both dated Sep. 4, 2014 which issued during the prosecution of Applicant's PCT/IL2014/050087. |
| Invitation to Pay Additional Fees dated Jun. 12, 2014 PCT/IL2014/050087. |
| An Office Action dated Jun. 17, 2014, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| An Office Action dated Jul. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| An Office Action dated May 23, 2014, which issued during the prosecution of U.S. Appl. No. 13/412,814. |
| Dominique Himbert; Mitral Regurgitation and Stenosis from Bioprosthesis and Annuloplasty Failure: Transcatheter approaches and outcomes , 24 pages Oct. 28, 2013. |
| An International Search Report and a Written Opinion both dated Mar. 17, 2014 which issued during the prosecution of Applicant's PCT/IL2013/050937. |
| An International Preliminary Report on Patentabiltv dated Dec. 2, 2013, which issued during the prosecution of Applicant's PCT/IL11/00582. |
| An Office Action dated Sep. 12, 2013, which issued during the prosecution of U.S. Appl. No. 13/412,814. |
| An Office Action dated Aug. 2, 2013, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| An International Preliminary Report on patentabiity dated Sep. 11, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000231. |
| An Office Action dated Jul. 2, 2014, which issued during the prosecution of U.S. Appl. No. 13/811,308. |
| An Office Action dated Jan. 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/161,921. |
| An Office Action dated Jul. 23, 2013, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| An Office Action dated Jul. 18, 2013, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
| An Office Action dated Nov. 8, 2013, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| An Office Action dated Jun. 4, 2014, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| An Office Action dated Aug. 13, 2012, which issued during the prosecution of U.S. Appl. No. 13/044,694. |
| An Office Action dated Jul. 2, 2012, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| An Office Action dated Feb. 3, 2014, which issued during the prosecution of U.S. Appl. No. 13/811,308. |
| An International Preliminary Report on patentabilty dated Feb. 11, 2014, which issued during the prosecution of Applicant's PCT/IL12/00292. |
| An International Preliminary Report on patentabilty dated Feb. 11, 2014, which issued during the prosecution of Applicant's PCT/IL12/00293. |
| A Notice of Allowance dated Aug. 15, 2014, which issued during the prosecution of U.S. Appl. No. 13/412,814. |
| An Office Action dated Aug. 14, 2012, which issued during the prosecution of U.S. Appl. No. 12/961,721. |
| U.S. Appl. No. 61/283,819, filed Dec. 8, 2009. |
| Notice of Allowance dated Sep. 29, 2016, which issued during the prosecution of U.S. Appl. No. 14/442,541. |
| U.S. Appl. No. 61/756,034, filed Jan. 24, 2013. |
| U.S. Appl. No. 61/756,049, filed Jan. 24, 2013. |
| Notice of Allowance dated Jul. 1, 2016, which issued during the prosecution of U.S. Appl. No. 14/442,541. |
| An Office Action dated Mar. 25, 2015, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| Notice of Allowance dated May 5, 2015, which issued during the prosecution of U.S. Appl. No. 12/840,463. |
| Georg Lutter, MD, et al; “Percutaneous Valve Replacement: Current State and Future Prospects”, The Annals of Thoracic Surgery ; vol. 78, pp. 2199-2206; Dec. 2004. |
| An Office Action dated Dec. 10, 2015, which issued during the prosecution of U.S. Appl. No. 14/237,258. |
| An International Preliminary Report on Patentability dated Jul. 28, 2015, which issued during the prosecution of Applicant's PCT/IL2014/050087. |
| An Office Action dated Nov. 27, 2015, which issued during the prosecution of U.S. Appl. No. 14/626,267. |
| An Office Action dated Jan. 21, 2016. which issued during the prosecution of U.S. Appl. No. 14/237,264. |
| An Office Action dated Apr. 13, 2016, which issued during the prosecution of U.S. Appl. No. 14/626,267. |
| An International Search Report and a Written Opinion both dated May 30, 2016, which issued during the prosecution of Applicant's PCT/IL2016/050125. |
| An Office Action dated Sep. 26, 2016, which issued during the prosecution of U.S. Appl. No. 14/763,004. |
| An Office Action dated Jan. 18, 2017, which issued during the prosecution of U.S. Appl. No. 14/626,267. |
| An Office Action dated Feb. 7, 2017, which issued during the prosecution of U.S. Appl. No. 14/689,608. |
| An Office Action dated Feb. 8, 2017, which issued during the prosecution of UK Patent Application No. 1613219.3. |
| An Office Action together dated Feb. 10, 2017, which issued during the prosecution of European Patent Application No. 12821522.5. |
| An International Search Report and a Written Opinion both dated Oct. 27, 2015, which issued during the prosecution of Applicant's PCT/IL2015/050792. |
| European Search Report dated Feb. 18, 2015, which issued during the prosecution of Applicant's European App No. 12821522.5. |
| Saturn Project—a novel solution for transcatheter heart valve replacement specifically designed to address clinical therapeutic needs on mitral valve: Dec. 2016. |
| Righini presentation EuroPCR May 2015 (Saturn)—(downloaded from: https://www.pcronline.com/Cases-resourcesimages/Resources/Course-videos-slides/2013/Cardiovascularinnovation-pipeline-Mitral-and-tricuspid-valve-interventions). |
| An International Preliminary Report on Patentability dated Jan. 31, 2017, which issued during the prosecution of Applicant's PCT/IL2015/050792. |
| An Office Action dated Jan. 30, 2015, which, issued during the prosecution of UK Patent Application No. 1413474.6. |
| An International Preliminary Report on Patentability dated May 19, 2015, which issued during the prosecution of Applicant's PCT/IL2013/050937. |
| Dusan Pavcnik, MD, PhD2, et al; “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement”, Cardiovascular Radiology, Radiology Apr. 1992, vol. 183, pp. 151-154. |
| Notice of Allowance dated Oct. 16, 2013, which issued during the prosecution of U.S. Appl. No. 13/675,119. |
| Notice of Allowance dated Feb. 11, 2015, which issued during the prosecution of U.S. Appl. No. 13/033,852. |
| Notice of Allowance dated Mar. 10, 2015, which issued during the prosecution of U.S. Appl. No. 13/811,308. |
| An Office Action dated Aug. 28, 2015, which issued during the prosecution of U.S. Appl. No. 14/237,264. |
| Notice of Allowance dated Apr. 8, 2016. which issued during the prosecution of U.S. Appl. No. 14/237,258. |
| Notice of Allowance dated May 10, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258. |
| Notice of Allowance dated May 20, 2016, which issued during the prosecution of U.S. Appl. No. 14/237,258. |
| An Office Action dated Jun. 30, 2015, which issued during the prosecution of U.S. Appl. No. 14/522,987. |
| An Office Action dated Feb. 25, 2016, which issued during the prosecution of U.S. Appl. No. 14/522,987. |
| Notice of Allowance dated Dec. 13, 2013. which issued during the prosecution of U.S. Appl. No. 13/675,119. |
| An International Preliminary Report on Patentability dated Aug. 8, 2017, which issued during the prosecution of Applicant's PCT/IL2016/050125. |
| Maisano (2015) TCR presentation re Cardiovalve. |
| U.S. Appl. No. 62/112,343, filed Feb. 5, 2015. |
| Edwards Lifesciences Corp. v. Cardiovalve Ltd., IPR2021-00383, Paper 10: Decision Granting Institution of Inter Partes Review (Dec. 10, 2021) (42 pages). |
| Edwards Lifesciences Corp. v. Cardiovalve Ltd., IPR2021-00383, Petitioners' Opposition to Patent Owner's Contingent Motion to Amend (Jan. 5, 2022) (32 pages). |
| Edwards Lifesciences Corp. v. Cardiovalve Ltd., IPR2021-00383, Petitioners' Reply to Patent Owner's Response (Jan. 5, 2022) (41 pages). |
| Ando, Tomo et al., Iatrogenic Ventricular Septal Defect Following Transcatheter Aortic Valve Replacement: A Systematic Review, 25 Heart, Lung, and Circulation 968-74 (Apr. 22, 2016) (7 pages). |
| Batista, Randas J. V. et al., Partial Left Ventriculectomy to Treat End-Stage Heart Disease, 64 Annals Thoracic Surgery 634-38 (1997) (5 pages). |
| Beall, Jr., Arthur C. et al., Clinical Experience with a Dacron Velour-Covered Teflon-Disc Mitral-Valve Prosthesis, 5 Annals Thoracic Surgery 402-10 (1968) (9 pages). |
| Edwards Lifesciences Corp. v. Cardiovalve Ltd., IPR2021-00383, Exhibit 1014: Transcript of proceedings held May 20, 2021 (May 26, 2021) (21 pages). |
| Edwards Lifesciences Corp. v. Cardiovalve Ltd., IPR2021-00383, Exhibit 1015: Facilitate, Merriam-Webster.com, https://www. www.merriam-webster.com/dictionary/facilitate (accessed May 27, 2021) (5 pages). |
| Edwards Lifesciences Corp. v. Cardiovalve Ltd., IPR2021-00383, Paper 12: Petitioners' Authorized Reply to Patent Owner's Preliminary Response (May 27, 2021) (9 pages). |
| Edwards Lifesciences Corp. v. Cardiovalve Ltd., IPR2021-00383, Paper 13: Patent Owner's Authorized Surreply to Petitioner's Reply to Patent Owner's Preliminary Response (Jun. 4, 2021) (8 pages). |
| Edwards Lifesciences Corp. v. Cardiovalve Ltd., IPR2021-00383, Paper 16: Institution Decision (Jul. 20, 2021) (51 pages). |
| Fucci, Carlo et al., Improved Results with Mitral Valve Repair Using New Surgical Techniques, 9 Eur. J. Cardiothoracic Surgery 621-27 (1995) (7 pages). |
| Maisano, Francesco et al., The Edge-To-Edge Technique: A Simplified Method to Correct Mitral Insufficiency, 13 Eur. J. Cardiothoracic Surgery 240-46 (1998) (7 pages). |
| Poirier, Nancy et al., A Novel Repair for Patients with Atrioventricular Septal Defect Requiring Reoperation for Left Atrioventricular Valve Regurgitation, 18 Eur. J. Cardiothoracic Surgery 54-61 (2000) (8 pages). |
| Stone, Gregg W. et al., Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repairand Replacement: Part 1: Clinical Trial Design Principles, 66 J. Am. C. Cardiology 278-307 (2015) (30 pages). |
| Urena, Marina et al., Transseptal Transcatheter Mitral Valve Replacement Using Balloon-Expandable Transcatheter Heart Valves, JACC: Cardiovascular Interventions 1905-19 (2017) (15 pages). |
| An International Search Report and a Written Opinion both dated May 3, 2022, which issued during the prosecution of Applicant's PCT/IL2021/051433. |
| An Office Action dated Jul. 8, 2022, which issued during the prosecution of U.S. Appl. No. 16/144,054. |
| An Office Action dated Jun. 28, 2022, which issued during the prosecution of U.S. Appl. No. 16/135,969. |
| An Office Action together with an English Summary dated May 7, 2022 which issued during the prosecution of Chinese Patent Application No. 201880058940.2. |
| Ex Parte Quayle dated May 2, 2022, which issued during the prosecution of U.S. Appl. No. 16/879,952. |
| IPR2021-00383 Final Written Decision dated Jul. 18, 2022. |
| IPR2021-01051 Preliminary Guidance Patent Owner's Motion to Amend dated Jun. 24, 2022. |
| Notice of Allowance dated May 4, 2022, which issued during the prosecution of U.S. Appl. No. 16/680,739. |
| An Office Action dated Mar. 18, 2022, which issued during the prosecution of U.S. Appl. No. 16/746,489. |
| An Office Action dated Jan. 26, 2022, which issued during the prosecution of U.S. Appl. No. 16/888,210. |
| Notice of Allowance dated Jan. 31, 2022, which issued during the prosecution of U.S. Appl. No. 17/479,418. |
| Notice of Allowance dated Mar. 22, 2022, which issued during the prosecution of U.S. Appl. No. 17/366,711. |
| Notice of Allowance dated Mar. 4, 2022, which issued during the prosecution of U.S. Appl. No. 16/768,909. |
| An Office Action dated Dec. 9, 2021, which issued during the prosecution of U.S. Appl. No. 16/135,969. |
| An Office Action dated Jan. 24, 2022, which issued during the prosecution of U.S. Appl. No. 16/135,466. |
| An Office Action dated Apr. 11, 2022, which issued during the prosecution of U.S. Appl. No. 17/473,472. |
| IPR2021-00383 Preliminary Guidance dated Jan. 31, 2022. |
| An Office Action dated Jul. 27, 2022, which issued during the prosecution of U.S. Appl. No. 16/881,350. |
| An Office Action dated Sep. 21, 2022, which issued during the prosecution of U.S. Appl. No. 16/776,581. |
| An Office Action dated Jul. 20, 2022, which issued during the prosecution of U.S. Appl. No. 17/101,787. |
| An Office Action dated Sep. 16, 2022, which issued during the prosecution of U.S. Appl. No. 16/135,466. |
| An Office Action dated Aug. 1, 2022, which issued during the prosecution of European Patent Application No. 18826823.9. |
| European Search Report dated Sep. 6, 2022 which issued during the prosecution of Applicant's European App No. 22161862.2. |
| IPR2021-01051 Petitioners' Reply to Preliminary Guidance dated Aug. 2, 2022. |
| IPR2021-01051 Patent Owner's Sur-Reply To Petitioners' Reply to Preliminary Guidance dated Aug. 23, 2022. |
| An Office Action dated Aug. 5, 2022, which issued during the prosecution of U.S. Appl. No. 16/760,147. |
| An Office Action dated Sep. 8, 2022, which issued during the prosecution of U.S. Appl. No. 16/896,858. |
| Number | Date | Country | |
|---|---|---|---|
| 20200315797 A1 | Oct 2020 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62112343 | Feb 2015 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 16730090 | Dec 2019 | US |
| Child | 16907615 | US | |
| Parent | 16507357 | Jul 2019 | US |
| Child | 16730090 | US | |
| Parent | 15978494 | May 2018 | US |
| Child | 16507357 | US | |
| Parent | 15541783 | US | |
| Child | 15978494 | US |
